Federal Life (FLFG) 10-K 1 Apr 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Apr. 01, 2019	Dec. 11, 2018
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Trading Symbol	FLF
Entity Registrant Name	Federal Life Group, Inc.
Entity Central Index Key	0001743886
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		3,530,250
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Public Float			$ 17.9
Entity Shell Company	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Securities available for sale, at fair value:
Fixed maturities (amortized cost; 2018, $187,035; 2017, $183,432)	$ 184,475	$ 188,452
Equity securities	6,004	6,209
Policy loans	9,581	9,852
Derivative instruments, at fair value	202	395
Total investments	200,262	204,908
Cash and cash equivalents	33,252	4,085
Real estate, property and equipment, net	2,130	2,151
Accrued investment income	1,908	1,886
Accounts receivable	498	538
Reinsurance recoverables	3,556	3,727
Prepaid reinsurance premiums	1,418	1,358
Deferred policy acquisition costs, net	13,533	12,179
Deferred sales inducement costs, net	1,348	867
Deferred tax asset, net	492	458
Other assets	511	202
Separate account asset	20,819	24,779
Total assets	279,727	257,138
Policy liabilities and accruals
Policyholder account balance	116,298	109,823
Future life policy benefits	71,992	71,927
Future accident and health policy benefits	345	386
Reserve for deposit type contracts	10,587	10,850
Other policyholder funds	1,398	1,970
Unearned revenue	1,367	1,387
Deferred reinsurance settlements	2,641	2,949
Taxes payable		7
Other liabilities	1,360	1,703
Separate account liability	20,819	24,779
Total liabilities	226,807	225,781
Stockholders' Equity
Common stock, par value $.01 per share, 4,010,150 shares authorized; issued and outstanding: 2018 - 3,530,150 shares 2017 - 0 shares	35
Additional paid-in capital	33,076
Accumulated other comprehensive income (loss)	(1,965)	4,757
Retained earnings	21,774	26,600
Total equity	52,920	31,357
Total Liabilities and Equity	$ 279,727	$ 257,138

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Statement Of Financial Position [Abstract]
Amortized cost	$ 187,035	$ 183,432
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	4,010,150	4,010,150
Common stock, shares issued	3,530,150	0
Common stock, shares outstanding	3,530,150	0

Consolidated Statement of Opera

Consolidated Statement of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenues
Insurance revenues	$ 11,301	$ 12,058
Net investment income	8,428	8,523
Net realized investment gains	878	2,228
Other revenues	211	194
Total revenues	20,818	23,003
Benefits and expenses
Policyholder benefits	13,865	13,712
Interest credit to policyholders	304	386
Operating costs and expenses	9,008	7,889
Amortization of deferred acquisition and sales inducement costs	1,645	2,108
Taxes, licenses and fees	736	716
Dividends to policyholders	66	66
Total benefits and expenses	25,624	24,877
Net loss before taxes	(4,806)	(1,874)
Tax expense	20	34
Net loss	(4,826)	(1,908)
Other comprehensive income (loss), net of tax:
Unrealized holding gains (losses) arising during the year (net of tax)	(7,607)	458
Adjustment to deferred acquisition costs (net of tax)	885	(55)
Other comprehensive income (loss)	(6,722)	403
Comprehensive loss	$ (11,548)	$ (1,505)
Basis loss per common share	$ (1.37)	$ (0.54)
Diluted loss per common share	$ (1.37)	$ (0.54)

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Balance at Dec. 31, 2016	$ 32,862			$ 3,549	$ 29,313
Net loss	(1,908)				(1,908)
Other comprehensive income (loss)	403			403
Balance at Dec. 31, 2017	31,357			4,757	26,600
Cumulative effect of adoption of new accounting principle				805	(805)
Initial public offering/conversion	33,077	$ 35	$ 33,042
Initial public offering/conversion, shares		3,530,150
Stock-based compensation	34		34
Net loss	(4,826)				(4,826)
Other comprehensive income (loss)	(6,722)			(6,722)
Balance at Dec. 31, 2018	$ 52,920	$ 35	$ 33,076	$ (1,965)	$ 21,774
Ending Balance, shares at Dec. 31, 2018		3,530,150

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net loss	$ (4,826)	$ (1,908)
Adjustments to reconcile net loss to net cash used in operating activities:
Realized investment gains, net	(878)	(2,228)
Amortization on investments	(54)	(42)
Depreciation	228	271
Stock-based compensation	34
Deferred insurance acquisition costs	(1,979)	(2,437)
Deferred sales inducement costs	(381)	(545)
Interest and amortization of deferred acquisition and sales inducement costs	1,645	2,108
Change in value of derivatives and other	368	(155)
Change in accrued investment income	(21)	(54)
Change in receivables	39	37
Change in reinsurance recoverable	171	(1,620)
Change in prepaid reinsurance premiums	(60)	(434)
Change in policy benefits	(549)	(1,053)
Change in unearned revenue	(20)	(8)
Change in deferred reinsurance settlements	(308)	1,437
Change in other	(929)	614
Net cash used in operating activities	(7,520)	(6,017)
Proceeds from investments sold or matured:
Fixed maturity securities	26,633	23,130
Equity securities	261	4,043
Derivatives	443	154
Policy loans	271	206
Costs of investments purchased:
Fixed maturity securities	(29,753)	(35,816)
Equity securities	(71)	(327)
Derivatives	(451)	(255)
Real estate additions	(107)	(84)
Purchase of property and equipment	(99)	(41)
Net cash used in investing activities	(2,873)	(8,990)
Policyholder account balances:
Deposits	15,195	19,300
Withdrawals	(9,019)	(8,482)
Net transfers from separate accounts	36	(115)
Receipts from promissory note	1,050
Net proceeds received from issuance of shares of common stock	32,298
Net cash provided by financing activities	39,560	10,703
Net increase (decrease) in cash	29,167	(4,304)
Cash, beginning of period	4,085	8,389
Cash, end of period	33,252	4,085
Cash paid during the year for:
Interest expense	13
Income taxes	20	34
Supplemental non-cash activity:
Deferral of sales inducements	381	$ 545
IPO expenses accrued not paid	270
Conversion of promissory note to common stock	$ 1,050

Organization and Basis of Prese

Organization and Basis of Presentation	12 Months Ended
	Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization and Basis of Presentation	FLG is a Pennsylvania corporation organized to be the stock holding company for Federal Life Mutual Holding Company and its subsidiaries (the “Predecessor”) following the conversion of Federal Life Mutual Holding Company from mutual to stock form (the “Conversion”). Federal Life Mutual Holding Company was subsequently renamed Federal Life Holding Company after the Conversion. Prior to the Conversion, FLG was not engaged in any significant operations and did not have any assets or liabilities. After the Conversion, which was completed on December 11, 2018, when FLG issued 3,530,150 shares at $10.00 per share for gross proceeds of $35.3 million, FLG’s primary assets are the outstanding capital stock of the Predecessor and a portion of the net proceeds of the Company’s IPO, which was completed on December 11, 2018. Prior to the Conversion, FLG was a direct, wholly-owned subsidiary of the Predecessor. Following the Conversion, the Company reorganized its corporate structure so that the Predecessor is a direct, wholly owned subsidiary of FLG. FLG now contains the accounts of its predecessor Federal Life Mutual Holding Company and subsidiaries and those accounts are now consolidated with those of FLG within the accompanying financial statements. The reorganization is considered a transaction between entities that are under common control. As a result, the consolidated financial statements prior to the IPO and the reorganization have been presented at their historical amounts. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of FLG and its subsidiaries, Federal Life Holding Company; FEDHO Holding Company (“FEDHO”); Federal Life Insurance Company (“Federal Life”), FED Mutual Financial Services, Inc.; and Americana Realty Company (“Americana”). Additionally, the IPO described above resulted in a change in control according to Business Combinations (Topic 805), however, the Company has elected not to apply push down accounting. Accordingly, the consolidated financial statements are presented at the Company’s historical carrying amounts. All intercompany transactions and balances have been eliminated in consolidation. Federal Life, a subsidiary of Federal Life Holding Company, completed a reorganization in 2016 in which it converted from a mutual to a stock insurance company within a newly created mutual holding company structure. As part of this reorganization, Federal Life Mutual Holding Company was formed as an Illinois mutual insurance holding company and Federal Life continued its existence as an Illinois stock life insurance company. All of the shares of Federal Life were issued to FEDHO, an intermediate holding company that, in turn, is a wholly-owned subsidiary of the Federal Life Holding Company. Federal Life has two wholly-owned non-insurance subsidiaries, Americana and FED Mutual Financial Services, Inc., discussed further below. Federal Life’s in force business is primarily comprised of traditional life policies (term insurance, whole life insurance, non-medical health insurance, and group life insurance), interest sensitive contracts, and fixed deferred annuity contracts. Federal Life primarily sells its interest sensitive life, whole life, term life, fixed and indexed annuities through a network of independent agents. Federal Life is licensed to sell new business in the District of Columbia and all states except Maine, Massachusetts, New Hampshire, New York and Vermont. Although Federal Life is licensed to sell products in 45 states, its primary markets are Illinois, Michigan, Ohio, California, Florida, Texas, and Wisconsin. Americana owns mineral rights in Arkansas, Georgia, Oklahoma and Texas. Americana earns royalty revenues from energy producers that are under agreement to drill for and produce oil and gas products on properties where Americana owns mineral rights. FED Mutual Financial Services, Inc. is a FINRA licensed broker/dealer that was established to distribute Federal Life’s variable annuity products.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Significant Accounting Policies	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements. The most significant estimates include those used in determining the capitalization and amortization of deferred policy acquisition costs (“DAC”), the valuation of investments, future policy benefits (traditional life contracts, immediate annuities, supplemental contracts with life contingencies, and accident and health), the fair value of stock-based compensation awards and the provision for income taxes. Actual results could differ from those estimates. Emerging Growth Company The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “Jobs Act”). As an emerging growth company, the Company utilizes the extended transition period provided in the Securities Act of 1933 for complying with new or revised accounting standards. Under this accommodation the Company may early adopt a new or revised accounting standard only if early adoption is permitted by the standard. Changes in accounting principles issued but not yet adopted described below reflect the Company’s status as an Emerging Growth Company and the extended adoption period allowed for such companies. Smaller Reporting Company Additionally, the Company qualifies as a “smaller reporting company” as defined by the SEC. In some instances, this permits the Company to provide scaled disclosures under Regulation S-K and Regulation S-X. Investments The Company’s principal investments are in fixed income and equity securities, and policy loans. The accounting policies related to the Company’s investments are as follows: Fixed Maturity and Equity Securities Fixed income securities include corporate and municipal bonds, U.S. government and agency bonds, residential mortgage-backed securities (“RMBS”), and commercial mortgage-backed securities (“CMBS”). Fixed income securities, which may be sold prior to their contractual maturity, are classified as available for sale and are carried at fair value. The difference between amortized cost and fair value, net of any deferred income taxes and DAC, is reflected as a component of accumulated other comprehensive income (“AOCI”). Cash received from calls, principal payments, make-whole payments, maturities and pay-downs is reflected as a component of proceeds from sales within the Consolidated Statements of Cash Flows. Equity securities include primarily exchange-traded funds and a commercial real estate fund. Equity securities are carried at fair value and are classified as available for sale. The difference between cost and fair value, net of deferred income taxes, is reflected as a component of accumulated other comprehensive income. Interest income on fixed maturity securities is included in net investment income and is recognized on an accrual basis using the effective yield method. The amortized cost of fixed maturity securities is adjusted for amortization of premiums and accretion of discounts to maturity, such amortization or accretion is also included in net investment income. In the case of mortgage-backed securities, the amortized cost is adjusted for amortization of premiums and accretion of discounts over the estimated life of the security. Accretion of the discount or amortization of the premium from mortgage-backed securities is recognized using a level effective yield method which considers the estimated timing and amount of prepayments originally anticipated and the actual prepayments received and currently anticipated. To the extent differences arise, the effective yield is recalculated on a retrospective basis. For other-than-temporarily impaired fixed income securities, the effective yield method utilizes the difference between the amortized cost basis at impairment and the cash flows expected to be collected. Accrual of income is suspended for other-than-temporarily impaired fixed income securities when the timing and amount of cash flows expected to be received is not reasonably estimable. Realized capital gains and losses include gains and losses on sales of investments, write-downs in value due to other-than-temporary declines in fair value and periodic changes in fair value. Realized capital gains and losses on sales of investments include fixed maturity securities with calls and prepayments and are determined on the basis of specific security identification. The Company recognizes other-than-temporary losses on fixed income securities when the decline in fair value is deemed other than temporary including when the Company has made the decision to sell or it is probable the Company will be required to sell the fixed income security before recovery of its amortized cost basis. If the Company does not expect to receive cash flows sufficient to recover the entire amortized cost basis of the fixed income security, the credit loss component of the impairment is recorded in the total net realized gains and losses line of the income statement, and the remaining amount of the unrealized loss deemed to be related to other factors is recognized in other comprehensive income (loss). Fixed income securities subject to other-than-temporary impairment write-downs continue to earn investment income when future expected payments are able to be reasonably estimated, and any discount or premium is recognized using the effective yield method over the expected life of the security; otherwise income recognition is discontinued. The Company recognizes other-than-temporary impairment losses on equity securities when the decline in fair value is deemed other than temporary including when the Company does not have a positive intent and ability to hold an impaired security until recovery. Such unrealized gains are recorded net of deferred income tax expense and unrealized losses are tax benefited. Management regularly reviews its fixed maturity and equity security portfolios to evaluate the necessity of recording impairment losses for other-than-temporary declines in the fair value of investments. A number of criteria are considered during this process including, but not limited to, the current fair value compared to the amortized cost of the security, the length of time the security’s fair value has been below amortized cost, and by how much, specific credit issues related to the issuer, the intent and ability of the Company to hold the investment until recovery and current economic conditions. The Company uses an 80% market/book ratio and a 12-month length of time as the basis screening tool for evaluating potential other-than-temporary impairment (“OTTI”) candidates. In addition, the Company will analyze situations where there has been a rapid and significant change in a security’s market value in the amount of  -10% or more to determine and understand underlying factors that may have caused a sudden decline in market value. Such impairment in fair value is included in realized investment gains (losses) and the cost basis of the security is reduced accordingly. The Company does not change the revised cost for subsequent increases in fair value. Policy Loans Policy loans are carried at the unpaid principal balances, which approximates fair value. Derivative Instruments Derivative instruments are used to hedge the Company’s exposure to indexed annuities and are held at fair market value. Cash and Cash Equivalents The Company defines cash as amounts in demand deposit accounts. The Company has deposits with certain financial institutions which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk to cash. Cash equivalents are principally comprised of money market funds and reported at fair value. Real Estate, Property and Equipment The Company’s real estate consists of its home office in Riverwoods, Illinois. The real estate, including related improvements, is carried at cost less accumulated depreciation. The Company uses the accelerated method based on an estimated useful life of 40 years for the building and 20 years for related improvements. The Company’s property and equipment is reported at cost less accumulated depreciation and is primarily made up of electronic data processing equipment and furniture. Depreciation is determined using the straight-line method over useful lives of three to ten years. Accrued Investment Income Accrued investment income includes interest and dividends earned but not yet received. Investment income is not accrued on securities in default. Accounts Receivable Accounts receivable consists primarily of balances due from agents. Reinsurance Recoverables and Prepaid Reinsurance Premiums Reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsurance of long duration contract are accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the original policies issued. The cost of reinsurance related to short duration policies is accounted for over the reinsurance contract period. Amounts recoverable from reinsurers for both short and long duration reinsurance agreements are estimated in a manner consistent with the claim liabilities and policy benefits associated with the reinsured policies. Recoverables from our reinsurers are any death claims that were ceded to the reinsurer. The GAAP reinsurance recoverable quantity is the present value of future reinsured death claims minus a percentage of the present value of net premium paid to the reinsurer. This quantity is analogous to the ceded reserve that we hold in our statutory statements. Prepaid reinsurance premium is that portion of premium paid to the reinsurer prior to the valuation date for reinsurance coverage beyond the valuation date. Deferred Policy Acquisition Costs (“DAC”) and Deferred Sales Inducement Costs (“DSIC”) The Company amortizes DAC related to traditional life policies over the entire premium paying period in proportion to the present value of actual historic and expected future gross premiums. The present value of expected premiums is based upon the premium requirement of each policy and assumptions for mortality, morbidity, persistency, certain expenses, and investment returns at policy issuance, that include provisions for adverse deviation and are consistent with the assumptions used to calculate future policyholder benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes. The Company does not currently hold any premium deficiency reserve. The Company amortizes DAC related to interest sensitive contracts and fixed and variable deferred annuity contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses and persistency are reasonably likely to impact significantly the rate of DAC amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These include investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease. The DAC balance includes adjustments to reflect the amount by which the amortization of DAC would increase or decrease if the unrealized capital gains or losses in the respective product portfolios were actually realized. The adjustments are recorded net of tax in accumulated other comprehensive income. DAC and deferred income taxes determined on unrealized capital gains and losses and reported in accumulated other comprehensive income recognize the impact on policyholder’s equity consistently with the amounts that would be recognized in the income statement on realized capital gains and losses. The Company does occasionally offer sales inducements to new customers, principally on indexed annuities and on certain fixed annuity products. These costs are deferred and amortized over time. Deferred Tax Asset Deferred taxes are provided on the temporary differences between the tax and financial statement basis of assets and liabilities. Deferred tax assets established on unrealized capital losses may be partially offset by valuation allowances. Other Assets Other assets consist primarily of suspense accounts and prepaid expenses. Separate Accounts The assets and liabilities of the separate accounts represent segregated funds administered and invested by the Company for purposes of funding variable annuity contracts for the exclusive benefit of variable annuity policyholders. Investment income and realized capital gains and losses of the separate accounts accrue directly to the policyholders and therefore, are not included in the Company’s Consolidated Statements of Operations and Comprehensive Income. Deposits to and surrenders and withdrawals from the separate accounts are reflected in separate account liabilities and are not included in consolidated cash flows. These contracts do not have any minimum guarantees and the investment risks associated with market value changes are borne entirely by the policyholder. The assets of the separate accounts, carried at fair value, are invested in mutual funds which are carried at fair value. Policyholder Account Balance Policyholder account balances relate to investment-type contracts and interest sensitive policies. Investment-type contracts principally include traditional individual fixed and variable annuities in the accumulation phase and non-variable group annuity contracts. Policyholder account balances are equal to policy account values, which consist of an accumulation of gross premium payments, interest credited, ranging from 1.35% to 7.0%, less expenses, mortality charges, and withdrawals. Future Life Policy Benefits and Future Accident and Health Policy Benefits The Company establishes liabilities for amounts payable under insurance policies, including traditional life insurance, traditional annuities, indexed annuities, and non-medical health insurance. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. Utilizing these assumptions, liabilities are established on a block of business basis. Future policy benefits for traditional life insurance policies, both participating and non-participating, are equal to the aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rates for the aggregate future policy benefit liabilities range from 5.0% to 9.0%. The Company’s amount of life insurance in-force is made up of approximately 93% participating policies and approximately 7% non-participating policies. The Company periodically reviews its estimates of actuarial liabilities for future policy benefits and compares them with actual experience. Differences between actual experience and the assumptions used in pricing these policies and riders and in the establishment of the related liabilities result in variances in profit and could result in losses. The effects of changes in such estimated liabilities are included in the results of operations in the period in which the changes occur. Reserve for Deposit Type Contracts The reserve for deposit type contracts include payout annuities without life contingencies and dividend accumulations and presented at amounts contractually due to policy holders. Other Policyholder Funds Other policyholder funds consist of advance premiums, policyholder dividends due and unpaid, policyholder dividends left on deposit and the provision for future policy benefit liabilities for individual and group traditional fixed annuities under non-life contingent payout. The Company accounts for the prepayment of premiums on its individual life, group life and health contracts as premium received in advance and applies the cash received to premiums when due. Policyholder dividends due and unpaid on participating policies and policyholder dividends left on deposit are presented at amounts contractually due to policyholders. Future policy benefit liabilities for individual and group traditional fixed annuities after annuitization are equal to the present value of expected future payments. Interest rates used in establishing such liabilities range from 2.25% to 7.5%. Unearned Revenue Unearned revenue is that portion of premium paid prior to the valuation date for insurance coverage after the valuation date. Deferred Reinsurance Settlements Deferred reinsurance settlements are the effect of reinsurance transactions that resulted in a net gain. This gain is amortized over the remaining life of the underlying reinsured contracts. Other Liabilities Other liabilities consist primarily of due and accrued commissions, accrued general expenses and taxes, and remittances not allocated. Income Taxes The Company files a consolidated tax return. The Company provides for federal income taxes based on amounts the Company believes it will ultimately owe or receive. Inherent in the provision for federal income taxes are estimates regarding the deductibility of certain expenses and the realization of certain tax credits. The Company recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. The Company did not have any accrued and recognized interest or penalties associated with unrecognized tax benefits for the years ending December 31, 2018 and 2017. The Company did not have any unrecognized tax benefits. Revenue and Expense Recognition Premiums related to traditional life and immediate annuities and supplemental contracts with life contingencies are recognized as revenues when due from policyholders. Policyholder benefits and expenses are booked against such revenues to recognize profits over the estimated lives of the policies. Premiums related to non-medical health and disability policies are recognized on a pro rata basis over the applicable contract term. Premiums related to interest sensitive and deposits related to deferred and immediate annuities without life contingencies are credited to policyholder account balances. Revenues from such contracts consist of amounts assessed against policyholder account balances for the cost of insurance (mortality risk), policy administration and early surrender. These assessments are recorded in policy fees in the period in which services are provided. Amounts that are charged to operations include interest credited and benefit claims incurred in excess of related policyholder account balances. Deposits are not considered revenue. Deposits are shown as a financing activity in the Consolidated Statement of Cash Flows. Policy fees for variable annuity products consist of fees assessed against the policyholder account values for contract maintenance, administration, mortality, expense and early surrender. Contract benefits incurred for variable annuity products include death, income, withdrawal and accumulation benefits. Deposits are not recorded as revenue. Interest credited to policyholder funds represents accrued or paid amounts on interest sensitive life policies and annuity contracts. Crediting rates for interest sensitive life policies and fixed annuities are adjusted periodically by the Company to reflect current market conditions subject to contractually guaranteed minimum rates. Operating costs and expenses are general expenses that are recognized when incurred. The Company does not issue any variable annuity contracts through separate accounts where the Company contractually guarantees to the policyholder total deposits made to the contract less any partial withdrawals plus a minimum return. Other Revenues Other revenues consist mainly of income from fees associated with the management of the Separate Account. Other Comprehensive Income Other comprehensive income includes the change in gross unrealized gains and losses on debt and equity securities, as well as the change in shadow DAC. This value is presented net of tax. Adopted Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, “Compensation - Stock Compensation”: Improvements to Employee Shared-Based Payment Accounting. The aspects of accounting guidance affected by this ASU are income taxes, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU was effective for annual reporting periods beginning after December 15, 2017. The Company adopted this ASU in the fourth quarter of fiscal 2018 upon the issuance of restricted stock and stock options to our employees. The adoption of the ASU did not have an impact on our financial statements as we did not previously have stock compensation. The Company has elected to account for forfeitures when they occur. In February 2018, the FASB issued ASU No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income,” which provides an option to reclassify stranded tax effects within AOCI to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (the “Tax Act”) is recorded. ASU No. 2018-02 is effective for fiscal years beginning after December 15, 2018 and should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the Tax Act is recognized. Early adoption is permitted. The Company early adopted ASU No. 2018-02 effective December 31, 2017 using the portfolio method, which resulted in the reclassification of $0.8 million of stranded tax effects from AOCI to retained earnings within the Company’s consolidated financial statements and disclosures. Issued Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU No. 2016-02 “Leases”, that will require recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements, This ASU affects accounting and disclosure more dramatically for lessees as accounting for lessors is mainly unchanged. This ASU is effective January 1, 2020. The adoption of ASU No. 2016-02 will not have an impact on the Company’s consolidated financial statements as we do not have any material leases. In August 2018, the FASB issued ASU No. 2018-12, “Targeted Improvements to the Accounting for Long-Duration Contracts,” which revises certain aspects of the measurement models and disclosure requirements for long duration insurance and investment contracts. The FASB’s objective in issuing this ASU is to improve, simplify, and enhance the accounting for long-duration contracts. The revisions include updating cash flow assumptions in the calculation of the liability for traditional life products, introducing the term ‘market risk benefit’ (“GNMRB”) and requiring all contract features meeting the definition of an MRB to be measured at fair value, simplifying the method used to amortize DAC and deferred sales inducement costs (“DSIC”) to a constant basis over the expected term of the related contracts rather than based on gross profits and enhancing disclosure requirements. This ASU is effective on January 1, 2022, the transition date (the remeasurement date) is January 1, 2020. Early adoption of this ASU is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements. In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging — Targeted Improvements to Accounting for Hedging Activities,” which changes the recognition and presentation requirements of hedge accounting. ASU No. 2017-12 is effective for annual periods beginning after December 15, 2019. Early adoption is permitted. The adoption of ASU No. 2017-12 is not expected to have a material impact on the Company’s consolidated financial statements. In March 2017, the FASB issued ASU No. 2017-08, “Receivables — Nonrefundable Fees and Other Costs: Premium Amortization on Purchased Callable Debt Securities,” which requires that certain premiums on callable debt securities be amortized to the earliest call date. ASU No. 2017-08 is effective for annual periods beginning after December 15, 2019. Early adoption is permitted. The adoption of ASU No. 2017-08 is not expected to have a material impact on the Company’s consolidated financial statements. In June 2016, the FASB issued, regarding recognition of unrealized gains and losses through income, ASU No. 2016-13 “Financial Instruments — Credit Losses: Measurement of Credit Losses of Financial Instruments,” which provides a new current expected credit loss model to account for credit losses on certain financial assets and off-balance sheet exposure. The model requires an entity to estimate lifetime credit losses related to such assets and exposure based on relevant information about past events, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The guidance also modifies the current other-than-temporary impairment guidance for available-for-sale debt securities to require the use of an allowance rather than a direct write down of the investment and replaces existing guidance for purchased credit deteriorated loans and debt securities. ASU No. 2016-13 is effective for annual reporting periods beginning after December 15, 2020 with early adoption permitted for annual periods beginning after December 15, 2018. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures. In January 2016, the FASB issued ASU No. 2016-01 “Financial Instruments — Overall: Recognition and Measurement of Financial Assets and Financial Liabilities,” which revises an entity’s accounting related to the classification and measurement of certain equity investments and the presentation of certain fair value changes for financial liabilities measured at fair value. The guidance also amends certain disclosure requirements associated with the fair value of financial instruments. ASU No. 2016-01 is effective for annual periods beginning after December 15, 2018. We expect the primary impact of this guidance on us will be in the recognition of gains or losses from changes in the fair value of our equity security investments through the statement of operations, rather than as unrealized gains or losses reflected in other comprehensive income. Additionally, there will no longer be a requirement for us to assess equity securities for other-than-temporary impairments, as such securities will be measured at fair value through net income. Note 4 provides further information as to our current level of unrealized gains or losses on these securities. In May 2014, the FASB issued an ASU 2014-09 “Revenue from Contracts with Customers”, related to revenue arising from contracts with customers. This ASU, which replaces most current revenue recognition guidance, including industry specific guidance, prescribes that an entity should recognize revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU will be effective on January 1, 2019 and may be adopted using either a full retrospective or a modified retrospective approach. The adoption of this pronouncement will not have a material impact our consolidated financial statements and disclosures.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair value estimates are made at specific points in time, based on relevant market information and information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale, at one time, the Company’s entire holding of a particular financial instrument. Although fair value estimates are calculated using assumptions that management believes are appropriate, changes in assumptions could significantly affect estimates. Fair value estimates are determined for existing financial instruments without attempting to estimate the value of anticipated future business and the value of assets and certain liabilities that are not considered financial instruments. Accordingly, the aggregate fair value estimates presented do not represent the underlying value of the Company. The Company has procedures in place to validate the fair values received from the independent pricing service. The Company assesses whether prices received represent a reasonable estimate of fair value through various controls designed to ensure that valuations represent a fair price, including calculation of portfolio returns, comparison of returns to corresponding benchmark returns, analysis of periodic changes in market prices, evaluation of corresponding market yields and spread levels, and comparing prices from multiple pricing sources. On an ongoing basis, the Company monitors the pricing service valuation methods and evaluates the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy. In addition, tax ramifications related to the realization of unrealized gains and losses can have a significant effect on fair value estimates and have not been considered in any of the estimates. The following methods and assumptions were used by the Company in estimating the fair value of its financial instruments: • Fixed maturity and equity securities: Fair values were determined by an independent pricing service and are downloaded from Clearwater Analytics. The Company does not own any securities for which a fair value was not provided by the pricing service or a custody statement. Fair values are checked for reasonableness. If a fair value had not been provided for a security, the Company would use a fair value estimated from yield data relating to instruments or securities with similar characteristics or as determined in good faith by the Company’s investment advisor, DWS. • Derivative instruments: Fair values were determined by an independent pricing service and are downloaded from Clearwater Analytics. Fair values are checked for reasonableness. • Policy loans: The carrying value of policy loans approximates fair value. • Cash and cash equivalents: The carrying value approximates fair value. • Policyholder account balance: For deposit liabilities, the fair value was based on the amount payable on demand at the reporting date and approximates fair value. Amounts related to the Company’s financial instruments as of December 31, 2018 and 2017 are as follows: Carrying\Fair Carrying\Fair Value Value December, 31 2018 December, 31 2017 (Dollar in thousands) Financial instruments recorded as assets: Fixed maturity securities $ 184,475 $ 188,452 Equity securities 6,004 6,209 Policy loans 9,581 9,852 Derivative instruments 202 395 Cash and cash equivalents 33,252 4,085 Separate account 20,819 24,779 Financial instruments recorded as liabilities: Policyholder account balance: Interest sensitive life contracts 41,478 41,078 Annuities 74,820 68,745 Dividend accumulations and other (1) 6,705 7,076 Separate account 20,819 24,779 (1) included within Reserve for deposit type funds in the consolidated balance sheet Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The hierarchy for inputs used in determining fair value maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Assets and liabilities recorded on the Consolidated Statements of Financial Position at fair value are categorized in the fair value hierarchy based on the observability of inputs to the valuation techniques as follows: • Level 1 — Assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company can access. • Level 2 — Assets and liabilities whose values are based on the following: Quoted prices for similar assets or liabilities in active markets; a. Quoted prices for identical or similar assets or liabilities in markets that are not active; or b. Valuation models whose inputs are observable, directly or indirectly, for substantially the full term of the asset or liability. • Level 3 — Assets and liabilities whose values are based on prices or valuation techniques that require that are both unobservable and significant to the overall fair value measurement. Unobservable inputs reflect the Company’s estimates of the assumptions that market participants would use in valuing the assets and liabilities. Summary of significant valuation techniques and inputs for assets and liabilities measured at fair value on a recurring basis: Level 1 measurements: Fixed maturity securities: Comprised of U.S. Treasury and GNMA agency securities. Valuation is based on unadjusted quoted prices for identical assets in active markets that the Company can access. Equities: Comprised of actively traded, exchange-listed equities. Valuation is based on unadjusted quoted prices for identical assets in active markets that the Company can access. Derivative instruments: Comprised of actively traded, exchange-listed derivatives. Valuation is based on unadjusted quoted prices for identical assets in active markets that the Company can access. Cash Equivalents: Comprised of money market funds. Market values for the money market funds are obtained from the fund managers. Separate account assets: Comprised of actively traded mutual funds that have daily quoted net asset values for identical assets that the Company can access. Market values for the actively traded mutual funds in which the separate account assets are invested are obtained daily from the fund managers. Level 2 measurements: Fixed maturity securities: States, political subdivisions, and corporate securities: As valuation technique the pricing vendor employs multi-dimensional relational application model which uses standard inputs including benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications. The pricing vendor also monitors market indicators, and industry and economic events. For high yield corporate securities, observations of equity and credit default swap curves are also used. Residential mortgage-backed securities: As valuation technique the pricing vendor employs option-adjusted spread (“OAS”) model and prepayment model as well as volatility driven, multi-dimensional spread tables using standard inputs including benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications plus new issue data, monthly prepayment information, and collateral performance. The pricing vendor also monitors market indicators, and industry and economic events. Commercial mortgage-backed securities: As valuation technique the pricing vendor employs multi-dimensional spread table and price tables using standard inputs including benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications plus new issue data, monthly prepayment information, collateral performance, and real estate analysis from third party. The pricing vendor also monitors market indicators, and industry and economic events. Level 3 measurements: Equities: The primary inputs to the valuation include quoted prices for identical or similar assets in markets that exhibit less liquidity relative to those markets supporting Level 2 fair value measurements, contractual cash flows, benchmark yields, collateral performance, credit spreads, and other estimates including custody statements. The following table presents the Company’s securities measured at fair value on a recurring basis as of December 31, 2018 and 2017: Recurring Fair Value Measurements at December 31, 2018 Using: Description Fair Values Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) (Dollar in thousands) Fixed maturity securities: U.S. government $ 4,057 $ 4,057 $ — $ — States, political subdivisions, other 30,989 — 30,989 — Corporate 106,286 — 106,286 — Residential mortgage-backed securities 37,522 — 37,522 — Commercial mortgage-backed securities 5,621 — 5,621 — Total Fixed maturities 184,475 4,057 180,418 — Equities 6,004 3,733 — 2,271 Derivative instruments 202 202 — — Cash equivalents (1) 33,252 33,252 — — Separate accounts (2) 20,819 20,819 — — Total $ 244,752 $ 62,063 $ 180,418 $ 2,271 Recurring Fair Value Measurements at December 31, 2017 Using: Description Fair Values Quote Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) (Dollar in thousands) Fixed maturity securities: U.S. government $ 4,162 $ 4,162 $ — $ — States, political subdivisions, other 27,614 — 27,614 — Corporate 109,395 — 109,395 — Residential mortgage-backed securities 43,086 — 43,086 — Commercial mortgage-backed securities 4,195 — 4,195 — Total Fixed maturities 188,452 4,162 184,290 — Equities 6,209 4,027 — 2,182 Derivative instruments 395 395 — — Cash equivalents (1) 4,085 4,085 — — Separate accounts (2) 24,779 24,779 — — Total $ 223,920 $ 37,448 $ 184,290 $ 2,182 (1) Cash equivalents are invested in money market funds with daily liquidity. The estimated fair value of cash equivalents is based on the estimated fair value of the underlying assets as provided by fund managers in daily net asset values and included in Level 1 assets. (2) Separate account assets are invested in money market funds with daily liquidity. The estimated fair value of separate account assets is based on the estimated fair value of the underlying assets as provided by fund managers in daily net asset values and included in Level 1 assets. The following table shows quantitative information about significant unobservable inputs related to the Level 3 fair value measurements reported in the tables used as of December 31, 2018 and 2017: Primary Significant Range Fair Value at December 31, 2018 Valuation Technique(s) Unobservable Inputs Min Max Weighted Average Rreef America REIT II $ 2,237 Discounted Cash Flows Discounted Rate 5.25 % 8.75 % 6.48 % Term capitalization rate 4.25 % 8.14 % 5.43 % Primary Significant Range Fair Value at December 31, 2017 Valuation Technique(s) Unobservable Inputs Min Max Weighted Average Rreef America REIT II $ 2,150 Discounted Cash Flows Discounted Rate 5.50 % 9.00 % 6.61 % Term capitalization rate 4.00 % 8.25 % 5.62 % The following table presents the rollforward of Level 3 assets held at fair value on a recurring basis as of December 31, 2018 and 2017: For the years ended December 31, 2018 2017 (Dollars in thousands) Balance, beginning of period $ 2,182 $ 3,169 Gains included in net income — 396 Settlements — (1,000 ) Unrealized gains (losses) in OCI 89 (383 ) Balance, end of period $ 2,271 $ 2,182

Investments

Investments	12 Months Ended
	Dec. 31, 2018
Investments Debt And Equity Securities [Abstract]
Investments	The Company’s principal investments are in fixed income and equity securities and policy loans. The following table presents the amortized cost, gross unrealized gains and (losses) and fair value of the Company’s fixed maturity and equities as of December 31, 2018 and 2017: December 31, 2018 Amortized Gross Unrealized Fair Cost Gains Losses Value (Dollars in thousands) U.S. government $ 4,063 $ 142 $ (148 ) $ 4,057 States, political subdivisions, other 30,881 472 (364 ) 30,989 Corporate 108,664 617 (2,995 ) 106,286 Residential mortgage-backed securities 37,755 455 (688 ) 37,522 Commercial mortgage-backed securities 5,672 73 (124 ) 5,621 Total fixed maturity securities 187,035 1,759 (4,319 ) 184,475 Equity securities 4,514 1,528 (38 ) 6,004 Total fixed maturity and equity securities $ 191,549 $ 3,287 $ (4,357 ) $ 190,479 December 31, 2017 Amortized Gross Unrealized Fair Cost Gains Losses Value (Dollars in thousands) U.S. government $ 4,075 $ 207 $ (120 ) $ 4,162 States, political subdivisions, other 26,850 876 (112 ) 27,614 Corporate 106,479 3,459 (543 ) 109,395 Residential mortgage-backed securities 41,818 1,480 (212 ) 43,086 Commercial mortgage-backed securities 4,210 26 (41 ) 4,195 Total fixed maturity securities 183,432 6,048 (1,028 ) 188,452 Equity securities 4,443 1,766 — 6,209 Total fixed maturity and equity securities $ 187,875 $ 7,814 $ (1,028 ) $ 194,661 The scheduled maturities for fixed income securities as of December 31, 2018 and 2017 are as follows: December 31, 2018 December 31, 2017 Amortized Fair Amortized Fair Cost Value Cost Value (Dollars in thousands) Due in one year or less $ 5,998 $ 6,041 $ 2,247 $ 2,288 Due after one year through five years 37,917 38,032 40,926 42,809 Due after five years through ten years 74,274 72,209 66,739 68,151 Due after ten years 25,419 25,050 27,492 27,923 Mortgage-backed securities 43,427 43,143 46,028 47,281 Total $ 187,035 $ 184,475 $ 183,432 $ 188,452 Actual maturities may differ from those scheduled as a result of prepayments by the issuers. Because of the potential for prepayment on mortgage-backed securities, they are not categorized by contractual maturity. The following table presents the sources of fixed maturity proceeds and the related gross investment gains (losses) at December 31, 2018 and 2017: 2018 Fixed Equity Derivative Maturities Securities Instruments (Dollars in thousands) Proceeds from sales or maturities $ 26,633 $ 261 $ 443 Gross gains from sales or maturities 641 261 729 Other-than-temporary-impairment (OTTI) losses (164 ) — — Gross losses from sales or maturities (48 ) — (541 ) 2017 Fixed Equity Derivative Maturities Securities Instruments (Dollars in thousands) Proceeds from sales or maturities $ 23,130 $ 4,043 $ 154 Gross gains from sales or maturities 200 1,957 183 Gross losses from sales or maturities (23 ) — (89 ) For the period ended December 31, 2018 a credit loss of $0.2 million was recognized through realized losses because the Company does not expect to fully recover the amortized cost value of a corporate bond and of two fixed income securities in the commercial mortgage backed sector held as available for sale. For the corporate bond, it was determined that it is probable that the Company will be unable to collect all amounts due, according to the contractual terms of the security. For the commercial mortgage backed securities, it was determined that that best estimate of the net present value of the future cash flow expected to be collected from these securities was significantly below their amortized cost values. A number of factors were analyzed to determine whether these impairments should be considered other-than-temporary, including but not limited to, fair market values of the securities, changes in fair market values, credit ratings, and an analysis of the underlying loan collateral with an assessment of the likelihood of full repayment of principal and interest. The credit loss reported was equal to the difference between amortized book value and the best estimate of the net present value of the projected cash flow expected to be recovered for the mortgage backed securities and between the amortized book value and the quoted market value of the corporate bond. The Company will evaluate future recovery estimates on a periodic basis. The following is a rollforward of credit related OTTI recognized in earnings as of December 31, 2018 and 2017: December 31, 2018 December 31, 2017 (Dollars in thousands) Balance at beginning of period $ — $ — Additions for credit related OTTI not previously reported 164 — Additions for increases in OTTI amounts previously recognized — — Balance at end of period $ 164 $ — The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income and equity security whose carrying value may be other-than-temporarily impaired. For each fixed income security in an unrealized loss position, the Company assesses whether management with the appropriate authority has made a decision to sell or whether it is probable that the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes. If a security meets either of these criteria, the security’s decline in fair value is deemed other than temporary and is recorded in earnings. If the Company has not made the decision to sell the fixed income security and it is not more likely than not the Company will be required to sell the fixed income security before recovery of its amortized cost basis, the Company evaluates if it expects to receive cash flows sufficient to recover the entire amortized cost basis of the security by comparing the estimated recovery value calculated by discounting the best estimate of future cash flows at the security’s original or current effective rate, as appropriate, with the amortized cost of the security. If the Company does not expect to receive cash flows sufficient to recover the entire amortized cost basis of the fixed income security, the credit loss component of the impairment is recorded in earnings, with the remaining amount of the unrealized loss deemed to be related to other factors and recognized in AOCI. For equity securities, the Company considers various factors, including whether the Company has the intent and ability to hold the equity security for a period of time sufficient to recover its cost basis. Where the Company lacks the intent and ability to hold to recovery, or believes the recovery period is extended, the equity security’s decline in fair value is considered other than temporary and is recorded in earnings. The Company’s portfolio monitoring process includes a quarterly review of all securities through a screening process which identifies instances where the fair value compared to amortized cost for fixed income securities and cost for equity securities is below established thresholds, and also includes the monitoring of other criteria such as ratings, ratings downgrades or payment defaults. The securities identified, in addition to other securities for which the Company may have a concern, are evaluated for potential other-than-temporary impairment using all reasonably available information relevant to the collectability or recovery of the security. Inherent in the Company’s evaluation of other-than-temporary impairment for these fixed income and equity securities are assumptions and estimates about the financial condition of the issue or issuer and its future earnings potential. Some of the factors considered in evaluating whether a decline in fair value is other than temporary are: 1) the length of time and extent to which the fair value has been less than amortized cost for fixed income securities, or cost for equity securities; 2) the financial condition, near-term and long-term prospects of the issue or issuer, including relevant industry specific market conditions and trends, geographic location and implications of rating agency actions and offering prices; and 3) the specific reasons that a security is in a significant unrealized loss position, including overall market conditions which could affect liquidity. The following table shows the fair value and gross unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at December 31, 2018 and December 31, 2017: December 31, 2018 Less than 12 months 12 months or longer Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized Description of securities Value Loss Value Loss Value Loss (Dollars in thousands) U.S. government $ — $ — $ 2,907 $ (148 ) $ 2,907 $ (148 ) States, political subdivisions, other 6,106 (103 ) 9,339 (261 ) 15,445 (364 ) Corporate 49,193 (1,886 ) 14,228 (1,109 ) 63,421 (2,995 ) Residential mortgage-backed securities 9,401 (158 ) 13,065 (530 ) 22,466 (688 ) Commercial mortgage-backed securities 2,003 (45 ) 1,502 (79 ) 3,505 (124 ) Equity securities 379 (38 ) — — 379 (38 ) Total $ 67,082 $ (2,230 ) $ 41,041 $ (2,127 ) $ 108,123 $ (4,357 ) December 31, 2017 Less than 12 months 12 months or longer Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized Description of securities Value Loss Value Loss Value Loss (Dollars in thousands) U.S. government $ 1,161 $ (31 ) $ 1,782 $ (89 ) $ 2,943 $ (120 ) States, political subdivisions, other 8,773 (86 ) 714 (26 ) 9,487 (112 ) Corporate 10,935 (169 ) 6,853 (374 ) 17,788 (543 ) Residential mortgage-backed securities 11,517 (126 ) 2,263 (86 ) 13,780 (212 ) Commercial mortgage-backed securities 2,039 (27 ) 77 (14 ) 2,116 (41 ) Total $ 34,425 $ (439 ) $ 11,689 $ (589 ) $ 46,114 $ (1,028 ) It is not more likely than not that the Company will be required to sell these investments before recovery of their amortized cost bases, which may be maturity. Net Investment Income Net investment income for the periods ended December 31, 2018 and 2017 is as follows: December 31, 2018 2017 (Dollars in thousands) Fixed maturity securities $ 7,301 $ 7,350 Equity securities 176 181 Real estate 123 149 Cash equivalents 76 32 Policy loans 711 723 Other 630 685 Subtotal 9,017 9,120 Investment expense 589 597 Net investment income $ 8,428 $ 8,523 Unrealized Capital Gains (Losses) Unrealized net capital gains and losses included in accumulated other comprehensive income at December 31, 2018 and 2017: December 31, 2018 Net Fair Gross Unrealized Unrealized Value Gains Losses Gain (Loss) (Dollars in thousands) Fixed income securities $ 184,475 $ 1,759 $ (4,319 ) $ (2,560 ) Equity securities 6,004 1,528 (38 ) 1,490 Net unrealized capital losses $ (1,070 ) December 31, 2017 Net Fair Gross Unrealized Unrealized Value Gains Losses Gain (Loss) (Dollars in thousands) Fixed income securities $ 188,452 $ 6,048 $ (1,028 ) $ 5,020 Equity securities 6,209 1,766 — 1,766 Net unrealized capital gains $ 6,786 At December 31, 2018 and 2017, securities with a market value of approximately $4.5 million and $4.7 million, respectively, were on deposit with governmental agencies as required by state insurance departments. Credit Risk The Company generally strives to maintain a diversified invested asset portfolio but is exposed to credit and other types of risks related to its holding in fixed income and equity securities. Such risk may be related to individual companies, sectors, or entire asset classes. The Company manages this risk by holding a diversified portfolio of securities and sectors and by limiting the amount of exposure to a single issuer or credit. For December 31, 2018 and December 31, 2017, approximately 23% and 25%, respectively, of the Company’s investments in fixed maturities were invested in commercial and residential mortgage-backed securities and approximately 57% and 58%, respectively, in corporate bonds. Approximately 5% and of the fixed income maturities were rated below investment grade. There is certain concentration risk from investments in companies that are engaged in similar activities and have similar economic characteristics. The largest corporate bond sector exposures at December 31, 2018 are consumer non-cyclical consisting of 11% of the total fixed income portfolio, banks 6%, communications 6%, real estate 5%, and energy 5%. The largest corporate bond sector exposures at December 31, 2017 were consumer non-cyclical consisting of 12% of the total fixed income portfolio, banks 6%, energy 6%, communications 5%, and real estate 5%. The Company uses equity index options to fully hedge its equity market exposure to index annuity products. These are exchange traded options and there is no credit risk.

Derivative Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2018
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Instruments	The Company uses derivatives to hedge its equity market exposure to index annuity products which are contracts that earn a return based on the change in the value of the S&P 500 index between annual index point dates. The Company buys and sells listed equity and index call options and call option spreads and there is no credit risk. The net premium is paid up front and there are no additional cash requirements or additional contingent liabilities. These contracts are held at fair market value on the Company’s balance sheet. At December 31, 2018 and 2017, these derivative hedges had a net market value of  $0.2 million and $0.4 million, with notional amounts of  $12.7 million and $8.5 million on call options purchased and $8.8 million and $6.0 million on call options written, as of December 31, 2018 and 2017, respectively.

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs, Deferred Sales Inducements and Lifetime Income Benefit Rider Reserves	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Deferred Policy Acquisition Costs, Deferred Sales Inducements and Lifetime Income Benefit Rider Reserves	The Company incurs significant costs in connection with acquiring new insurance business. Costs that vary with and relate to the successful production of new business are deferred as DAC. Such costs consist principally of commissions and policy issue expenses. The recovery of DAC is dependent upon the future profitability of the related business. DAC on life insurance or investment-type contracts are amortized in proportion to gross premiums, gross margins or gross profits, depending on the type of contract as described below. Sales inducements such as bonuses on index annuity products are also deferred and amortized through expenses over future time periods. The balances of and changes in deferred acquisition costs were as follows as of and for the years ended December 31, 2018 and 2017: December 31, 2018 2017 (Dollars in thousands) Balance, beginning of period $ 12,179 $ 11,940 Capitalization of commissions, sales and issue expenses 1,979 2,437 Accrual of interest 550 544 Amortization (2,295 ) (2,659 ) Change in Shadow DAC 1,120 (83 ) Balance, end of period $ 13,533 $ 12,179 The balances of and changes in deferred sales inducement costs were as follows as of and for the years ended December 31, 2018 and 2017: December 31, 2018 2017 (Dollars in thousands) Balance, beginning of period $ 867 $ 315 Capitalization of sales inducement costs 381 545 Accrual of interest 34 18 Amortization 66 (11 ) Balance, end of period $ 1,348 $ 867

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	12 Months Ended
	Dec. 31, 2018
Text Block [Abstract]
Accumulated Other Comprehensive Income	The components of accumulated other comprehensive income (loss) are as follows: Unrealized Accumulated Investment Other Gains (Losses) Shadow DAC Comprehensive Income (Loss) (Dollars in thousands) Balance, January 1, 2017 $ 3,997 $ (448 ) $ 3,549 Available-for-sale investment gains (losses) arising during the year: Fixed maturity securities net of tax of $227 440 — 440 Equity securities net of tax of $9 18 — 18 Change in Shadow DAC net of tax benefit of $28 — (55 ) (55 ) Cumulative effect of adoption of new accounting principle (see Note 2) 904 (99 ) 805 Balance, December 31, 2017 5,359 (602 ) 4,757 Available-for-sale investment gains (losses) arising during the year: Fixed maturity securities net of tax benefit of $207 (7,372 ) — (7,372 ) Equity securities net of tax benefit of $63 (235 ) — (235 ) Change in Shadow DAC net of tax of $235 — 885 885 Balance, December 31, 2018 $ (2,248 ) $ 283 $ (1,965 ) Accumulated other comprehensive income includes gross unrealized gains and losses on debt and equity securities, as well as shadow DAC. This value is presented net of tax.

Reinsurance and Policy Provisio

Reinsurance and Policy Provisions	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Reinsurance and Policy Provisions	The Company reinsures a portion of its business to other insurance companies to limit mortality risk and limit its overall financial exposure. The Company reinsures amounts over its $250,000 retention limit on certain life policies through yearly renewable term (“YRT”) and coinsurance agreements. Although these reinsurance agreements contractually obligate the reinsurers to reimburse the Company, they do not discharge the Company from its primary liability and obligations to policyholders. Federal Life’s reinsured business under life reinsurance agreements is primarily ceded to two reinsurers; Optimum Re and SCOR Global Life Americas. The Company regularly monitors the financial strength of its reinsurers. We believe the assuming companies will be able to honor all contractual commitments, based on our periodic review of their financial statements, insurance industry reports and reports filed with state insurance departments. In 2016, the Company entered into a reinsurance arrangement with Optimum Re, covering the majority of its inforce level term business. This is defined as a long duration contract and the expected recovery cost of reinsurance is spread over the life of the policies. This arrangement cedes 80% of the mortality risk on every such policy on a YRT basis that was not already ceded as described in the previous paragraph. In 2017, the Company entered into a reinsurance arrangement with Optimum Re, covering the majority of its inforce universal life business, which cedes 80% of the mortality risk on every such policy. These transactions resulted in deferred reinsurance gains. As of September 30, 2018, Federal Life decided to no longer participate in the FEGLI reinsurance program. This resulted in lower assumed premium and assumed benefits in the fourth quarter but had no effect on net income. The termination of this program will also result in lower assumed premium and assumed benefits in 2019, compared with 2018, but will have no effect on net income. Total insurance revenues as of December 31, 2018 include $2.1 million reinsurance assumed and $2.8 million reinsurance ceded. As of December 31, 2018, we have reinsurance recoverables of $3.6 million and prepaid reinsurance premium of $1.4 million. Total insurance revenues as of December 31, 2017 included $2.6 million reinsurance assumed and $2.1 million reinsurance ceded. As of December 31, 2017, we had reinsurance recoverables of $3.7 million and prepaid reinsurance premium of $1.4 million.

Separate Accounts

Separate Accounts	12 Months Ended
	Dec. 31, 2018
Separate Accounts Disclosure [Abstract]
Separate Accounts	The Company utilizes separate accounts to record and account for assets and liabilities for a variable annuity line of business. In accordance with the product recorded within the separate account, all of the assets are considered legally insulated. The legal insulation of the separate account assets prevents such assets from being generally available to satisfy claims resulting from the general account. Separate account assets are invested in mutual funds. The estimated fair value of separate account assets is based on the estimated fair values of the underlying assets as published by fund managers in daily net asset values and are the basis for current transactions. As of December 31, 2018 and 2017, the Company’s separate account statement included legally insulated assets of $20.8 million and $24.8 million, respectively. The separate account verification between years is as follows: December 31, 2018 2017 (Dollars in thousands) Balance, beginning of year $ 24,779 $ 21,513 Cost of bonds and stocks acquired 170 299 Net realized and unrealized increase (decrease) (2,272 ) 3,467 Deduction consideration for bonds and stocks disposed of (1,925 ) (562 ) Change in other assets 67 62 Balance, end of period $ 20,819 $ 24,779 The Company has no accumulation products with guarantees backed by the general account. The Company no longer issues new contracts under the separate account.

Policyholder Liabilities

Policyholder Liabilities	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Policyholder Liabilities	Future life and accident and health policy benefits as of December 31, 2018 and 2017 are as follows: December 31, 2018 2017 (Dollars in thousands) Traditional life contracts $ 61,972 $ 62,311 Immediate annuities and pension plan 6,608 6,774 Supplemental contracts with life contingencies 3,118 2,522 Accident and health 345 386 Accident death benefits 132 132 Disability 162 188 $ 72,337 $ 72,313 The following table highlights the key assumptions generally used in calculating the reserve for life-contingent contract benefits: Product Mortality Interest Rate Estimation Method Immediate fixed annuities 1971, 1983, 2000, and 2012 annuity mortality tables Rates range from 2.3% to 6.5% Present value of expected future benefits based on historical experience Traditional life insurance Actual company experience plus loading Rates range from 2.5% to 5.75% Net level premium reserve method using the Company's withdrawal experience Accident and health Actual company experience plus loading n/a Unearned premium; additional contract reserves for mortality risk The total net reserves for life-contingent products are greater than the actuarial present value of the difference between future cash flow disbursements and future cash flow receipts using best estimate assumptions. Consequently, no premium deficiency reserve is required for this block of business. Policyholder account balances as of December 31, 2018 and 2017 are as follows: December 31, 2018 2017 (Dollars in thousands) Interest sensitive life contracts $ 41,478 $ 41,078 Annuities 74,820 68,745 $ 116,298 $ 109,823 The following table highlights the key contract provisions relating to policyholder funds: Product Interest Rate Withdrawal/surrender charges Interest-sensitive life insurance Rates range from 3% to 7% Either a percentage of account balance or a dollar amount grading off generally over 20 years Fixed annuities Rates range from 0% to 8% Either a declining or level charge generally over 9 years or less Other investment contract Rates range from 2% to 6% No explicit charge assumed Policyholder funds activity for the years ended December 31, 2018 and 2017 is as follows: December 31, 2018 2017 (Dollars in thousands) Balance, beginning of year $ 109,823 $ 99,440 Deposits 14,191 17,994 Interest credited 4,473 4,353 Benefits (2,751 ) (2,734 ) Surrenders and partial withdrawals (5,258 ) (4,835 ) COI charges (2,900 ) (2,973 ) Contract charges (1,316 ) (1,307 ) Net transfers from separate accounts 36 (115 ) Balance, end of period $ 116,298 $ 109,823 Reserve for deposit type contracts as of December 31, 2018 and 2017 are as follows: December 31, 2018 2017 (Dollars in thousands) Payout annuities without life contingencies $ 3,882 $ 3,774 Dividend accumulations and other 6,705 7,076 $ 10,587 $ 10,850

Real Estate

Real Estate	12 Months Ended
	Dec. 31, 2018
Real Estate [Abstract]
Real Estate	Real estate consists of the Company’s home office property and is carried at cost less accumulated depreciation. The following table presents the Company’s real estate holdings at December 31, 2018 and 2017: December 31, 2018 2017 (Dollars in thousands) Land $ 405 $ 405 Building and other 8,485 8,378 8,890 8,783 Accumulated depreciation (6,946 ) (6,828 ) Real estate, net $ 1,944 $ 1,955

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2018
Property Plant And Equipment [Abstract]
Property and Equipment	Property and equipment is carried at cost less accumulated depreciation. The following table presents the Company’s property and equipment at December 31, 2018 and 2017: December 31, 2018 2017 (Dollars in thousands) EDP equipment $ 3,973 $ 3,955 Furniture 1,596 1,522 EDP equipment & furniture cost 5,569 5,477 Accumulated depreciation (5,383 ) (5,281 ) Property and equipment, net $ 186 $ 196

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	Effective 2016, the parent holding company and subsidiaries files a consolidated federal income tax return. Tax years 2015 through 2018 are subject to examination by the IRS. Prior to 2016, consolidated federal income tax returns were filed under Federal Life as the ultimate parent. Internal Revenue Code Section 382 (“Section 382”) limits how much of a loss carryforward can be used to offset taxable income when there is a change of ownership. The Company will be restricted in its ability to utilize loss carryforwards as a result of a 2018 change in ownership. The annual limit is estimated to be approximately $1.0 million and the total limit is estimated to be approximately $15.0 million. The Company has recorded a net deferred tax asset of $0.5 million reflecting the partial benefit of $15.0 million in loss carryforwards, of which $13.1 million expire in varying amounts between 2025 and 2032. Realization of this asset is dependent on generating sufficient taxable income prior to expiration of the loss carryforwards. A valuation allowance has been established to account for the Company’s assessment that the entire loss carryforward will likely not be recovered. Although realization of the net deferred tax asset is not assured, management believes it is more likely than not that all of the net deferred tax asset will be realized. The amount of the net deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced. The Company had no liability for unrecognized tax benefits at December 31, 2018 and 2017 and believes it is reasonably possible that the liability will not significantly increase within the next twelve months. No amounts have been accrued for interest or penalties. The Tax Act limits life reserves for tax purposes to the greater of net surrender value or 92.81% of required reserves. This did not have a meaningful impact on the assets on the Company’s balance sheet. The components of income tax expense for the periods ended December 31, 2018 and 2017 are as follows: For the years ended December 31, 2018 2017 (Dollars in thousands) Current $ 20 $ 34 Deferred — — Provision for income tax $ 20 $ 34 The federal income tax provisions differ from the amounts determined by multiplying pre-tax income attributable to the Company by the statutory federal income tax rate of 21% and 34% for December 31, 2018 and 2017, respectively. For the years ended December 31, 2018 2017 (Dollars in thousands) Income tax benefits at statutory rate $ (1,009 ) $ (637 ) Tax effect from change in enacted tax rate — 805 Other 1,029 (134 ) Income tax expense $ 20 $ 34 Effective tax rate 0.4 % 1.8 % The tax effects of temporary differences that give rise to significant portions of the Company’s net deferred federal tax asset (liability) from operations are shown below. For the years ended December 31, 2018 2017 (Dollars in thousands) Deferred federal tax assets: Difference between financial reporting and the tax basis of: Operating loss carryforward $ 3,163 $ 5,859 Other than temporary impairments 974 947 Deferred premiums 846 734 Life policy reserves 821 600 Other 262 380 Deferred reinsurance settlements 555 619 Total deferred tax assets 6,621 9,139 Deferred federal tax liabilities: Difference between financial reporting and the tax basis of: Deferred acquisition costs and sales inducements 2,549 2,147 Net unrealized gains (229 ) 1,421 Reinsurance recoverable 648 766 Amortized discount on bonds 94 138 Other 211 143 Fixed assets (10 ) 53 Total deferred tax liabilities 3,263 4,668 Net 3,358 4,471 Less valuation allowance (2,866 ) (4,013 ) Net deferred tax asset $ 492 $ 458 The Company has net operating loss carryforwards for income tax purposes at December 31, 2018 as follows (dollars in thousands): Expiring 2025 3,066 2026 2,188 2027 1,353 2028 2,664 2029 509 2030 2,240 2031 1,119 2032 — N/A 1,921 Total $ 15,060 Recent changes in corporate tax laws regarding net operating losses (“NOLs”) have resulted in taxable income for tax periods after 2017 being limited to an 80% deduction with no carrybacks and indefinite carryforwards. The Company’s NOL’s are limited by Section 382 as discussed.

Employer's Disclosures About Po

Employer's Disclosures About Postretirement Benefits	12 Months Ended
	Dec. 31, 2018
Compensation And Retirement Disclosure [Abstract]
Employer's Disclosures About Postretirement Benefits	The Company has a 401k plan covering substantially all employees. Employees may contribute up to 10% of their total pretax cash compensation. The Company matches employee contributions up to 3% of cash compensation at the time of the contribution. The Company may match employee contributions up to an additional 3% of cash compensation at the end of the year. The Company’s contribution during the years ended December 31, 2018 and 2017, was $95,000 and $90,000, respectively.

Debt and Federal Home Loan Bank

Debt and Federal Home Loan Bank Advances	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Debt and Federal Home Loan Bank Advances	Effective June 29, 2018, the Company issued an exchangeable promissory note to ICG with a principle amount up to $2.0 million and a 3.75% interest rate. The $1.05 million that was outstanding as of the IPO date on December 11, 2018 converted into 105,000 shares of common stock of FLG. The Company has not issued any debt or other credit obligations as of December 31, 2018. The Company has no commitments in the form of loan guarantees. Federal Life is a member of the Federal Home Loan Bank (“FHLB”) and has access to various advances and other funding products. As of December 31, 2018 and 2017, there are no advances or other credit outstanding with the FHLB.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
Related Party Transactions	All the outstanding shares of Americana and FED Mutual Financial Services, Inc. are owned by Federal Life. Federal Life is owned by FEDHO Holding Company which is owned by Federal Life Holding Company which is owned by Federal Life Group. During 2018 and 2017, Americana paid $0.5 million and $1.4 million, respectively, in common stock dividends to Federal Life. As of December 31, 2018 and 2017, Americana reported $0.1 million and $41,000, respectively, as dividends due to its parent company, Federal Life. This amount is generally settled within 60 days. Federal Life received $12.5 million in paid-in surplus from parent after the IPO was completed on December 11, 2018. Federal Life distributed $3.05 million in dividends to FEDHO Holding Company on September 6, 2017, which was immediately contributed back to Federal Life as paid-in and contributed surplus. In both 2018 and 2017, Federal Life Holding Company paid $20,000 in interest to Federal Life on the Guaranty Fund Note that was issued in 2016. Federal Life provides financial support for Fed Mutual Financial Services, Inc. to continue its operations. All related party transactions eliminate in consolidation. The promissory note described in Note 15, above, converted into shares of the Company which were issued to ICG on December 11, 2018. As a result, ICG is a controlling shareholder of the Company.

Retirement and Share-based Comp

Retirement and Share-based Compensation Plans	12 Months Ended
	Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Retirement and Share-based Compensation Plans	On December 11, 2018, FLG granted restricted stock awards and nonqualified stock options to the Company’s executive officers and board members at the closing of the Company’s IPO, under the 2018 Equity Incentive Plan (the “Plan”). The Plan, which was effective October 23, 2018, authorized the issuance of up to 480,000 shares of our common stock in the form of incentive stock options, nonqualified stock options, or restricted stock. Of this, 140,000 shares were granted as restricted stock awards and 215,000 shares were used to award stock options. At December 31, 2018, we had 125,000 shares of common stock available for future grant under the Plan. All restricted stock awards and options granted under the Plan have a service vesting period of 4 years, vesting 25% on December 10, 2019, and the The fair value of the stock options granted was estimated using a Black-Scholes option pricing model that uses the assumptions noted in the following table. Due to FLG’s limited public history, the expected stock price volatility was based on the historical volatility of comparable companies’ stock for a period of time equal to the expected term of the option. FLG believes that the use of historical volatility of this peer group is currently the best estimate of expected volatility of the market price of FLG’s common stock. The expected term of the options granted is calculated using the ‘plain-vanilla’ calculation provided in the guidance of the SEC’s Staff Accounting Bulletin Topic 14. As FLG does not currently pay a dividend and does not intend to pay a dividend in 2019, a dividend yield of 0% was used. The risk-free interest rate is the yield on the grant dates of the options of U.S. Treasury zero coupon securities with a maturity comparable to the expected term of the options. The fair market value of the stock options granted during the year ended December 31, 2018, was calculated using the following weighted average assumptions: Expected volatility 39.21 % Expected life (in years) 6.25 Dividend yield 0 % Risk-free interest rate 2.78 % Weighted average grant date fair value of options granted 4.31 The estimated grant date fair value of the options was approximately $0.9 million. The fair market value of the restricted stock awards on the grant date was $1.4 million. Changes in the number of restricted stock awards outstanding during the years ended December 31, 2018 and 2017 are as follows: Number of Restricted Stock Awards Weighted-Average Grant Date Fair Value per Share (Dollars in thousands, except per share data) Outstanding at January 1, 2017 — $ — Granted — — Canceled — — Exercised — — Outstanding at December 31, 2017 — — Granted 140,000 10.00 Canceled — — Exercised — — Outstanding at December 31, 2018 140,000 Changes in the number of stock options outstanding during the years ended December 31, 2018 and 2017 are as follows: Number of Shares Weighted-Average Exercise Price per Share Total Exercise Price (Dollars in thousands, except per share data) Outstanding at January 1, 2017 — $ — $ — Granted — — — Canceled — — — Exercised — — — Outstanding at December 31, 2017 — — — Granted 215,000 10.00 2,150 Canceled — — — Exercised — — — Outstanding at December 31, 2018 215,000 $ 2,150 Compensation costs are recognized on a straight-line basis over the service vesting period. The Company has elected to account for forfeitures when they occur. The following table summarizes compensation expense, which is all non-cash expense, recognized as a result of share-based compensation: Year Ended December 31, 2018 2017 (Dollars in thousands) Restricted stock awards $ 20 $ — Stock options 14 — $ 34 $ —

Statutory Financial Information

Statutory Financial Information and Dividend Restrictions	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Statutory Financial Information and Dividend Restrictions	Under Illinois insurance regulations, Federal Life is required to maintain minimum surplus of $1.5 million. As of December 31, 2018 and 2017, its surplus exceeded the minimum required. Federal Life Holding Company is required to maintain a minimum surplus of $2.0 million. Federal Life’s statutory loss and capital and surplus, as determined in accordance with accounting practices prescribed or permitted by the State of Illinois Department of Insurance were approximately $2.6 million and $24.9 million, respectively, as of December 31, 2018, compared with a gain of $0.2 million and capital and surplus of $14.9 million, respectively, as of December 31, 2017. Each licensed insurance company’s state of domicile imposes minimum risk-based capital requirements that were developed by the National Association of Insurance Commissioners (“NAIC”). The formulas for determining the amount of risk-based capital utilize various weighting factors that are applied to financial balances or various levels of activity based on the perceived degree of risk. Either the weighting factors or the methodology for determining the weighting factors is specified by the NAIC. Regulatory compliance is determined by a ratio of total adjusted capital, as defined by the NAIC, to authorized control level risk-based capital, as defined by the NAIC. Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified corrective action. Federal Life exceeded the minimum risk-based capital requirements at December 31, 2018 and December 31, 2017. Federal Life faces regulatory restrictions on the ability to transfer funds to the registrant (Federal Life Group) in the form of cash dividends, loans or advances. As of December 31, 2018, the amount of restricted net assets amounts to $22.4 million, which equals 90% of Federal Life’s capital and surplus of $24.9 million. The Illinois Department of Insurance has approved permitted practice to admit a $2.0 million Guaranty Fund Note issued by Federal Life Holding Company and purchased by Federal Life. Without this approval, this asset would be non-admitted on Federal Life’s statutory statement and total Capital and Surplus would be reduced by $2.0 million to $22.9 million. This amount exceeds the required minimum capital. The Guaranty Fund Note eliminates in the consolidated financial statements and does not impact the accompanying reported financials.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2018
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	The Company is involved in various legal actions for which it will establish liabilities where appropriate. In the opinion of the Company’s management, based on the advice of legal counsel, the resolution of such litigation is not expected to have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Earnings Per Share and Stockhol

Earnings Per Share and Stockholders' Equity	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Earnings Per Share and Stockholders’ Equity	The pro forma earnings per common share—basic and diluted—presented on the accompanying consolidated statements of operations and comprehensive income (loss) is intended to depict the impact of the Conversion because neither FLG, nor the Predecessor, had, prior to the Conversion, any outstanding common shares. The following table presents the pro forma net loss and weighted average common shares outstanding used in the computation of earnings per common share and earnings per common share – assuming dilution for the following years: Pro Forma for the years ended December 31, 2018 2017 (Dollar in thousands, except per share data) Numerator: Net loss - numerator for earnings per common share $ (4,826 ) $ (1,908 ) Denominator: Weighted average common shares outstanding 3,530,150 3,530,150 Effect of dilutive securities: Stock options 215,000 215,000 Restricted stock awards 140,000 140,000 Denominator for earnings per common share - assuming dilution 3,885,150 3,885,150 Earnings per common share $ (1.37 ) $ (0.54 ) Earnings per common share - assuming dilution $ (1.37 ) $ (0.54 )

Quarterly Financial Information

Quarterly Financial Information	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information	As a smaller reporting company, as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and Item 10(f)(1) of Regulation S-K, the Company has elected to comply with certain scaled disclosure reporting obligations, and therefore is not required to provide this information.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	Subsequent to December 31, 2018, on January 16, 2019, the Company issued 100 shares of common stock at the original IPO issuance price of $10.00 per share to account for the receipt of a previously delayed subscription stock order form. This equity issuance accounts for the change in our total number of outstanding shares from 3,530,150 as of December 16, 2018, as disclosed in our Form 10-Q for the quarterly period ended September 30, 2018, to 3,530,250 as of April 1, 2019. On March 25, 2019, the Company announced that it had given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its common stock from the Nasdaq Capital Market. The Company also announced its intention to deregister its common stock under Section 12(b) of the Securities Exchange Act of 1934 (the “Exchange Act”). The Company currently anticipates that it will file with the SEC and Nasdaq a Form 25, Notification of Removal of Listing and/or Registration Under Section 12(b) the Exchange Act, relating to the delisting and deregistration on or about April 4, 2019, with the delisting of its common stock taking effect no earlier than ten days thereafter. As a result, the Company expects that the last trading day of its common stock on the Nasdaq Capital Market will be on or about April 15, 2019, after which it will seek quotation of its shares on the OTC Pink Open Market. Further, on or about April 15, 2019, the Company intends to file a Form 15 with the SEC to suspend the Company's reporting obligations under Section 15(d) of the Exchange Act.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements. The most significant estimates include those used in determining the capitalization and amortization of deferred policy acquisition costs (“DAC”), the valuation of investments, future policy benefits (traditional life contracts, immediate annuities, supplemental contracts with life contingencies, and accident and health), the fair value of stock-based compensation awards and the provision for income taxes. Actual results could differ from those estimates.
Emerging Growth Company	Emerging Growth Company The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “Jobs Act”). As an emerging growth company, the Company utilizes the extended transition period provided in the Securities Act of 1933 for complying with new or revised accounting standards. Under this accommodation the Company may early adopt a new or revised accounting standard only if early adoption is permitted by the standard. Changes in accounting principles issued but not yet adopted described below reflect the Company’s status as an Emerging Growth Company and the extended adoption period allowed for such companies.
Smaller Reporting Company	Smaller Reporting Company Additionally, the Company qualifies as a “smaller reporting company” as defined by the SEC. In some instances, this permits the Company to provide scaled disclosures under Regulation S-K and Regulation S-X.
Investments	Investments The Company’s principal investments are in fixed income and equity securities, and policy loans. The accounting policies related to the Company’s investments are as follows:
Fixed Maturity and Equity Securities	Fixed Maturity and Equity Securities Fixed income securities include corporate and municipal bonds, U.S. government and agency bonds, residential mortgage-backed securities (“RMBS”), and commercial mortgage-backed securities (“CMBS”). Fixed income securities, which may be sold prior to their contractual maturity, are classified as available for sale and are carried at fair value. The difference between amortized cost and fair value, net of any deferred income taxes and DAC, is reflected as a component of accumulated other comprehensive income (“AOCI”). Cash received from calls, principal payments, make-whole payments, maturities and pay-downs is reflected as a component of proceeds from sales within the Consolidated Statements of Cash Flows. Equity securities include primarily exchange-traded funds and a commercial real estate fund. Equity securities are carried at fair value and are classified as available for sale. The difference between cost and fair value, net of deferred income taxes, is reflected as a component of accumulated other comprehensive income. Interest income on fixed maturity securities is included in net investment income and is recognized on an accrual basis using the effective yield method. The amortized cost of fixed maturity securities is adjusted for amortization of premiums and accretion of discounts to maturity, such amortization or accretion is also included in net investment income. In the case of mortgage-backed securities, the amortized cost is adjusted for amortization of premiums and accretion of discounts over the estimated life of the security. Accretion of the discount or amortization of the premium from mortgage-backed securities is recognized using a level effective yield method which considers the estimated timing and amount of prepayments originally anticipated and the actual prepayments received and currently anticipated. To the extent differences arise, the effective yield is recalculated on a retrospective basis. For other-than-temporarily impaired fixed income securities, the effective yield method utilizes the difference between the amortized cost basis at impairment and the cash flows expected to be collected. Accrual of income is suspended for other-than-temporarily impaired fixed income securities when the timing and amount of cash flows expected to be received is not reasonably estimable. Realized capital gains and losses include gains and losses on sales of investments, write-downs in value due to other-than-temporary declines in fair value and periodic changes in fair value. Realized capital gains and losses on sales of investments include fixed maturity securities with calls and prepayments and are determined on the basis of specific security identification. The Company recognizes other-than-temporary losses on fixed income securities when the decline in fair value is deemed other than temporary including when the Company has made the decision to sell or it is probable the Company will be required to sell the fixed income security before recovery of its amortized cost basis. If the Company does not expect to receive cash flows sufficient to recover the entire amortized cost basis of the fixed income security, the credit loss component of the impairment is recorded in the total net realized gains and losses line of the income statement, and the remaining amount of the unrealized loss deemed to be related to other factors is recognized in other comprehensive income (loss). Fixed income securities subject to other-than-temporary impairment write-downs continue to earn investment income when future expected payments are able to be reasonably estimated, and any discount or premium is recognized using the effective yield method over the expected life of the security; otherwise income recognition is discontinued. The Company recognizes other-than-temporary impairment losses on equity securities when the decline in fair value is deemed other than temporary including when the Company does not have a positive intent and ability to hold an impaired security until recovery. Such unrealized gains are recorded net of deferred income tax expense and unrealized losses are tax benefited. Management regularly reviews its fixed maturity and equity security portfolios to evaluate the necessity of recording impairment losses for other-than-temporary declines in the fair value of investments. A number of criteria are considered during this process including, but not limited to, the current fair value compared to the amortized cost of the security, the length of time the security’s fair value has been below amortized cost, and by how much, specific credit issues related to the issuer, the intent and ability of the Company to hold the investment until recovery and current economic conditions. The Company uses an 80% market/book ratio and a 12-month length of time as the basis screening tool for evaluating potential other-than-temporary impairment (“OTTI”) candidates. In addition, the Company will analyze situations where there has been a rapid and significant change in a security’s market value in the amount of  -10% or more to determine and understand underlying factors that may have caused a sudden decline in market value. Such impairment in fair value is included in realized investment gains (losses) and the cost basis of the security is reduced accordingly. The Company does not change the revised cost for subsequent increases in fair value.
Policy Loans	Policy Loans Policy loans are carried at the unpaid principal balances, which approximates fair value.
Derivative Instruments	Derivative Instruments Derivative instruments are used to hedge the Company’s exposure to indexed annuities and are held at fair market value.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company defines cash as amounts in demand deposit accounts. The Company has deposits with certain financial institutions which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk to cash. Cash equivalents are principally comprised of money market funds and reported at fair value.
Real Estate, Property and Equipment	Real Estate, Property and Equipment The Company’s real estate consists of its home office in Riverwoods, Illinois. The real estate, including related improvements, is carried at cost less accumulated depreciation. The Company uses the accelerated method based on an estimated useful life of 40 years for the building and 20 years for related improvements. The Company’s property and equipment is reported at cost less accumulated depreciation and is primarily made up of electronic data processing equipment and furniture. Depreciation is determined using the straight-line method over useful lives of three to ten years.
Accrued Investment Income	Accrued Investment Income Accrued investment income includes interest and dividends earned but not yet received. Investment income is not accrued on securities in default.
Accounts Receivable	Accounts Receivable Accounts receivable consists primarily of balances due from agents.
Reinsurance Recoverables and Prepaid Reinsurance Premiums	Reinsurance Recoverables and Prepaid Reinsurance Premiums Reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsurance of long duration contract are accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the original policies issued. The cost of reinsurance related to short duration policies is accounted for over the reinsurance contract period. Amounts recoverable from reinsurers for both short and long duration reinsurance agreements are estimated in a manner consistent with the claim liabilities and policy benefits associated with the reinsured policies. Recoverables from our reinsurers are any death claims that were ceded to the reinsurer. The GAAP reinsurance recoverable quantity is the present value of future reinsured death claims minus a percentage of the present value of net premium paid to the reinsurer. This quantity is analogous to the ceded reserve that we hold in our statutory statements. Prepaid reinsurance premium is that portion of premium paid to the reinsurer prior to the valuation date for reinsurance coverage beyond the valuation date.
Deferred Policy Acquisition Costs (“DAC”) and Deferred Sales Inducement Costs (“DSIC”)	Deferred Policy Acquisition Costs (“DAC”) and Deferred Sales Inducement Costs (“DSIC”) The Company amortizes DAC related to traditional life policies over the entire premium paying period in proportion to the present value of actual historic and expected future gross premiums. The present value of expected premiums is based upon the premium requirement of each policy and assumptions for mortality, morbidity, persistency, certain expenses, and investment returns at policy issuance, that include provisions for adverse deviation and are consistent with the assumptions used to calculate future policyholder benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes. The Company does not currently hold any premium deficiency reserve. The Company amortizes DAC related to interest sensitive contracts and fixed and variable deferred annuity contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses and persistency are reasonably likely to impact significantly the rate of DAC amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These include investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease. The DAC balance includes adjustments to reflect the amount by which the amortization of DAC would increase or decrease if the unrealized capital gains or losses in the respective product portfolios were actually realized. The adjustments are recorded net of tax in accumulated other comprehensive income. DAC and deferred income taxes determined on unrealized capital gains and losses and reported in accumulated other comprehensive income recognize the impact on policyholder’s equity consistently with the amounts that would be recognized in the income statement on realized capital gains and losses. The Company does occasionally offer sales inducements to new customers, principally on indexed annuities and on certain fixed annuity products. These costs are deferred and amortized over time.
Deferred Tax Asset	Deferred Tax Asset Deferred taxes are provided on the temporary differences between the tax and financial statement basis of assets and liabilities. Deferred tax assets established on unrealized capital losses may be partially offset by valuation allowances.
Other Assets	Other Assets Other assets consist primarily of suspense accounts and prepaid expenses.
Separate Accounts	Separate Accounts The assets and liabilities of the separate accounts represent segregated funds administered and invested by the Company for purposes of funding variable annuity contracts for the exclusive benefit of variable annuity policyholders. Investment income and realized capital gains and losses of the separate accounts accrue directly to the policyholders and therefore, are not included in the Company’s Consolidated Statements of Operations and Comprehensive Income. Deposits to and surrenders and withdrawals from the separate accounts are reflected in separate account liabilities and are not included in consolidated cash flows. These contracts do not have any minimum guarantees and the investment risks associated with market value changes are borne entirely by the policyholder. The assets of the separate accounts, carried at fair value, are invested in mutual funds which are carried at fair value.
Policyholder Account Balance	Policyholder Account Balance Policyholder account balances relate to investment-type contracts and interest sensitive policies. Investment-type contracts principally include traditional individual fixed and variable annuities in the accumulation phase and non-variable group annuity contracts. Policyholder account balances are equal to policy account values, which consist of an accumulation of gross premium payments, interest credited, ranging from 1.35% to 7.0%, less expenses, mortality charges, and withdrawals.
Future Life Policy Benefits and Future Accident and Health Policy Benefits	Future Life Policy Benefits and Future Accident and Health Policy Benefits The Company establishes liabilities for amounts payable under insurance policies, including traditional life insurance, traditional annuities, indexed annuities, and non-medical health insurance. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. Utilizing these assumptions, liabilities are established on a block of business basis. Future policy benefits for traditional life insurance policies, both participating and non-participating, are equal to the aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rates for the aggregate future policy benefit liabilities range from 5.0% to 9.0%. The Company’s amount of life insurance in-force is made up of approximately 93% participating policies and approximately 7% non-participating policies. The Company periodically reviews its estimates of actuarial liabilities for future policy benefits and compares them with actual experience. Differences between actual experience and the assumptions used in pricing these policies and riders and in the establishment of the related liabilities result in variances in profit and could result in losses. The effects of changes in such estimated liabilities are included in the results of operations in the period in which the changes occur.
Reserve for Deposit Type Contracts	Reserve for Deposit Type Contracts The reserve for deposit type contracts include payout annuities without life contingencies and dividend accumulations and presented at amounts contractually due to policy holders.
Other Policyholder Funds	Other Policyholder Funds Other policyholder funds consist of advance premiums, policyholder dividends due and unpaid, policyholder dividends left on deposit and the provision for future policy benefit liabilities for individual and group traditional fixed annuities under non-life contingent payout. The Company accounts for the prepayment of premiums on its individual life, group life and health contracts as premium received in advance and applies the cash received to premiums when due. Policyholder dividends due and unpaid on participating policies and policyholder dividends left on deposit are presented at amounts contractually due to policyholders. Future policy benefit liabilities for individual and group traditional fixed annuities after annuitization are equal to the present value of expected future payments. Interest rates used in establishing such liabilities range from 2.25% to 7.5%.
Unearned Revenue	Unearned Revenue Unearned revenue is that portion of premium paid prior to the valuation date for insurance coverage after the valuation date.
Deferred Reinsurance Settlements	Deferred Reinsurance Settlements Deferred reinsurance settlements are the effect of reinsurance transactions that resulted in a net gain. This gain is amortized over the remaining life of the underlying reinsured contracts.
Other Liabilities	Other Liabilities Other liabilities consist primarily of due and accrued commissions, accrued general expenses and taxes, and remittances not allocated.
Income Taxes	Income Taxes The Company files a consolidated tax return. The Company provides for federal income taxes based on amounts the Company believes it will ultimately owe or receive. Inherent in the provision for federal income taxes are estimates regarding the deductibility of certain expenses and the realization of certain tax credits. The Company recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. The Company did not have any accrued and recognized interest or penalties associated with unrecognized tax benefits for the years ending December 31, 2018 and 2017. The Company did not have any unrecognized tax benefits.
Revenue and Expense Recognition	Revenue and Expense Recognition Premiums related to traditional life and immediate annuities and supplemental contracts with life contingencies are recognized as revenues when due from policyholders. Policyholder benefits and expenses are booked against such revenues to recognize profits over the estimated lives of the policies. Premiums related to non-medical health and disability policies are recognized on a pro rata basis over the applicable contract term. Premiums related to interest sensitive and deposits related to deferred and immediate annuities without life contingencies are credited to policyholder account balances. Revenues from such contracts consist of amounts assessed against policyholder account balances for the cost of insurance (mortality risk), policy administration and early surrender. These assessments are recorded in policy fees in the period in which services are provided. Amounts that are charged to operations include interest credited and benefit claims incurred in excess of related policyholder account balances. Deposits are not considered revenue. Deposits are shown as a financing activity in the Consolidated Statement of Cash Flows. Policy fees for variable annuity products consist of fees assessed against the policyholder account values for contract maintenance, administration, mortality, expense and early surrender. Contract benefits incurred for variable annuity products include death, income, withdrawal and accumulation benefits. Deposits are not recorded as revenue. Interest credited to policyholder funds represents accrued or paid amounts on interest sensitive life policies and annuity contracts. Crediting rates for interest sensitive life policies and fixed annuities are adjusted periodically by the Company to reflect current market conditions subject to contractually guaranteed minimum rates. Operating costs and expenses are general expenses that are recognized when incurred. The Company does not issue any variable annuity contracts through separate accounts where the Company contractually guarantees to the policyholder total deposits made to the contract less any partial withdrawals plus a minimum return.
Other Revenues	Other Revenues Other revenues consist mainly of income from fees associated with the management of the Separate Account.
Other Comprehensive Income	Other Comprehensive Income Other comprehensive income includes the change in gross unrealized gains and losses on debt and equity securities, as well as the change in shadow DAC. This value is presented net of tax.
Adopted Accounting Pronouncements and Issued Accounting Pronouncements Not Yet Adopted	Adopted Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, “Compensation - Stock Compensation”: Improvements to Employee Shared-Based Payment Accounting. The aspects of accounting guidance affected by this ASU are income taxes, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU was effective for annual reporting periods beginning after December 15, 2017. The Company adopted this ASU in the fourth quarter of fiscal 2018 upon the issuance of restricted stock and stock options to our employees. The adoption of the ASU did not have an impact on our financial statements as we did not previously have stock compensation. The Company has elected to account for forfeitures when they occur. In February 2018, the FASB issued ASU No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income,” which provides an option to reclassify stranded tax effects within AOCI to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (the “Tax Act”) is recorded. ASU No. 2018-02 is effective for fiscal years beginning after December 15, 2018 and should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the Tax Act is recognized. Early adoption is permitted. The Company early adopted ASU No. 2018-02 effective December 31, 2017 using the portfolio method, which resulted in the reclassification of $0.8 million of stranded tax effects from AOCI to retained earnings within the Company’s consolidated financial statements and disclosures. Issued Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU No. 2016-02 “Leases”, that will require recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements, This ASU affects accounting and disclosure more dramatically for lessees as accounting for lessors is mainly unchanged. This ASU is effective January 1, 2020. The adoption of ASU No. 2016-02 will not have an impact on the Company’s consolidated financial statements as we do not have any material leases. In August 2018, the FASB issued ASU No. 2018-12, “Targeted Improvements to the Accounting for Long-Duration Contracts,” which revises certain aspects of the measurement models and disclosure requirements for long duration insurance and investment contracts. The FASB’s objective in issuing this ASU is to improve, simplify, and enhance the accounting for long-duration contracts. The revisions include updating cash flow assumptions in the calculation of the liability for traditional life products, introducing the term ‘market risk benefit’ (“GNMRB”) and requiring all contract features meeting the definition of an MRB to be measured at fair value, simplifying the method used to amortize DAC and deferred sales inducement costs (“DSIC”) to a constant basis over the expected term of the related contracts rather than based on gross profits and enhancing disclosure requirements. This ASU is effective on January 1, 2022, the transition date (the remeasurement date) is January 1, 2020. Early adoption of this ASU is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements. In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging — Targeted Improvements to Accounting for Hedging Activities,” which changes the recognition and presentation requirements of hedge accounting. ASU No. 2017-12 is effective for annual periods beginning after December 15, 2019. Early adoption is permitted. The adoption of ASU No. 2017-12 is not expected to have a material impact on the Company’s consolidated financial statements. In March 2017, the FASB issued ASU No. 2017-08, “Receivables — Nonrefundable Fees and Other Costs: Premium Amortization on Purchased Callable Debt Securities,” which requires that certain premiums on callable debt securities be amortized to the earliest call date. ASU No. 2017-08 is effective for annual periods beginning after December 15, 2019. Early adoption is permitted. The adoption of ASU No. 2017-08 is not expected to have a material impact on the Company’s consolidated financial statements. In June 2016, the FASB issued, regarding recognition of unrealized gains and losses through income, ASU No. 2016-13 “Financial Instruments — Credit Losses: Measurement of Credit Losses of Financial Instruments,” which provides a new current expected credit loss model to account for credit losses on certain financial assets and off-balance sheet exposure. The model requires an entity to estimate lifetime credit losses related to such assets and exposure based on relevant information about past events, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The guidance also modifies the current other-than-temporary impairment guidance for available-for-sale debt securities to require the use of an allowance rather than a direct write down of the investment and replaces existing guidance for purchased credit deteriorated loans and debt securities. ASU No. 2016-13 is effective for annual reporting periods beginning after December 15, 2020 with early adoption permitted for annual periods beginning after December 15, 2018. The Company is currently assessing the impact of the guidance on its consolidated financial statements and disclosures. In January 2016, the FASB issued ASU No. 2016-01 “Financial Instruments — Overall: Recognition and Measurement of Financial Assets and Financial Liabilities,” which revises an entity’s accounting related to the classification and measurement of certain equity investments and the presentation of certain fair value changes for financial liabilities measured at fair value. The guidance also amends certain disclosure requirements associated with the fair value of financial instruments. ASU No. 2016-01 is effective for annual periods beginning after December 15, 2018. We expect the primary impact of this guidance on us will be in the recognition of gains or losses from changes in the fair value of our equity security investments through the statement of operations, rather than as unrealized gains or losses reflected in other comprehensive income. Additionally, there will no longer be a requirement for us to assess equity securities for other-than-temporary impairments, as such securities will be measured at fair value through net income. Note 4 provides further information as to our current level of unrealized gains or losses on these securities. In May 2014, the FASB issued an ASU 2014-09 “Revenue from Contracts with Customers”, related to revenue arising from contracts with customers. This ASU, which replaces most current revenue recognition guidance, including industry specific guidance, prescribes that an entity should recognize revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU will be effective on January 1, 2019 and may be adopted using either a full retrospective or a modified retrospective approach. The adoption of this pronouncement will not have a material impact our consolidated financial statements and disclosures.

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Carrying Amount and Fair Value of Financial Instruments	Amounts related to the Company’s financial instruments as of December 31, 2018 and 2017 are as follows: Carrying\Fair Carrying\Fair Value Value December, 31 2018 December, 31 2017 (Dollar in thousands) Financial instruments recorded as assets: Fixed maturity securities $ 184,475 $ 188,452 Equity securities 6,004 6,209 Policy loans 9,581 9,852 Derivative instruments 202 395 Cash and cash equivalents 33,252 4,085 Separate account 20,819 24,779 Financial instruments recorded as liabilities: Policyholder account balance: Interest sensitive life contracts 41,478 41,078 Annuities 74,820 68,745 Dividend accumulations and other (1) 6,705 7,076 Separate account 20,819 24,779 (1) included within Reserve for deposit type funds in the consolidated balance sheet
Summary of Securities Measured at Fair Value on Recurring Basis	The following table presents the Company’s securities measured at fair value on a recurring basis as of December 31, 2018 and 2017: Recurring Fair Value Measurements at December 31, 2018 Using: Description Fair Values Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) (Dollar in thousands) Fixed maturity securities: U.S. government $ 4,057 $ 4,057 $ — $ — States, political subdivisions, other 30,989 — 30,989 — Corporate 106,286 — 106,286 — Residential mortgage-backed securities 37,522 — 37,522 — Commercial mortgage-backed securities 5,621 — 5,621 — Total Fixed maturities 184,475 4,057 180,418 — Equities 6,004 3,733 — 2,271 Derivative instruments 202 202 — — Cash equivalents (1) 33,252 33,252 — — Separate accounts (2) 20,819 20,819 — — Total $ 244,752 $ 62,063 $ 180,418 $ 2,271 Recurring Fair Value Measurements at December 31, 2017 Using: Description Fair Values Quote Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) (Dollar in thousands) Fixed maturity securities: U.S. government $ 4,162 $ 4,162 $ — $ — States, political subdivisions, other 27,614 — 27,614 — Corporate 109,395 — 109,395 — Residential mortgage-backed securities 43,086 — 43,086 — Commercial mortgage-backed securities 4,195 — 4,195 — Total Fixed maturities 188,452 4,162 184,290 — Equities 6,209 4,027 — 2,182 Derivative instruments 395 395 — — Cash equivalents (1) 4,085 4,085 — — Separate accounts (2) 24,779 24,779 — — Total $ 223,920 $ 37,448 $ 184,290 $ 2,182
Summary of Quantitative Information About Significant Unobservable Inputs Related to Level 3 Fair Value Measurements	The following table shows quantitative information about significant unobservable inputs related to the Level 3 fair value measurements reported in the tables used as of December 31, 2018 and 2017: Primary Significant Range Fair Value at December 31, 2018 Valuation Technique(s) Unobservable Inputs Min Max Weighted Average Rreef America REIT II $ 2,237 Discounted Cash Flows Discounted Rate 5.25 % 8.75 % 6.48 % Term capitalization rate 4.25 % 8.14 % 5.43 % Primary Significant Range Fair Value at December 31, 2017 Valuation Technique(s) Unobservable Inputs Min Max Weighted Average Rreef America REIT II $ 2,150 Discounted Cash Flows Discounted Rate 5.50 % 9.00 % 6.61 % Term capitalization rate 4.00 % 8.25 % 5.62 %
Summary of Rollforward of Level 3 Assets Held at Fair Value on Recurring Basis	The following table presents the rollforward of Level 3 assets held at fair value on a recurring basis as of December 31, 2018 and 2017: For the years ended December 31, 2018 2017 (Dollars in thousands) Balance, beginning of period $ 2,182 $ 3,169 Gains included in net income — 396 Settlements — (1,000 ) Unrealized gains (losses) in OCI 89 (383 ) Balance, end of period $ 2,271 $ 2,182

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2018
Investments Debt And Equity Securities [Abstract]
Summary of Amortized Cost, Gross Unrealized Gains and (Losses) and Fair Value of the Company's Fixed Maturity and Equities	The following table presents the amortized cost, gross unrealized gains and (losses) and fair value of the Company’s fixed maturity and equities as of December 31, 2018 and 2017: December 31, 2018 Amortized Gross Unrealized Fair Cost Gains Losses Value (Dollars in thousands) U.S. government $ 4,063 $ 142 $ (148 ) $ 4,057 States, political subdivisions, other 30,881 472 (364 ) 30,989 Corporate 108,664 617 (2,995 ) 106,286 Residential mortgage-backed securities 37,755 455 (688 ) 37,522 Commercial mortgage-backed securities 5,672 73 (124 ) 5,621 Total fixed maturity securities 187,035 1,759 (4,319 ) 184,475 Equity securities 4,514 1,528 (38 ) 6,004 Total fixed maturity and equity securities $ 191,549 $ 3,287 $ (4,357 ) $ 190,479 December 31, 2017 Amortized Gross Unrealized Fair Cost Gains Losses Value (Dollars in thousands) U.S. government $ 4,075 $ 207 $ (120 ) $ 4,162 States, political subdivisions, other 26,850 876 (112 ) 27,614 Corporate 106,479 3,459 (543 ) 109,395 Residential mortgage-backed securities 41,818 1,480 (212 ) 43,086 Commercial mortgage-backed securities 4,210 26 (41 ) 4,195 Total fixed maturity securities 183,432 6,048 (1,028 ) 188,452 Equity securities 4,443 1,766 — 6,209 Total fixed maturity and equity securities $ 187,875 $ 7,814 $ (1,028 ) $ 194,661
Summary of Scheduled Maturities for Fixed Income Securities	The scheduled maturities for fixed income securities as of December 31, 2018 and 2017 are as follows: December 31, 2018 December 31, 2017 Amortized Fair Amortized Fair Cost Value Cost Value (Dollars in thousands) Due in one year or less $ 5,998 $ 6,041 $ 2,247 $ 2,288 Due after one year through five years 37,917 38,032 40,926 42,809 Due after five years through ten years 74,274 72,209 66,739 68,151 Due after ten years 25,419 25,050 27,492 27,923 Mortgage-backed securities 43,427 43,143 46,028 47,281 Total $ 187,035 $ 184,475 $ 183,432 $ 188,452
Summary of Fixed Maturity Proceeds and the Related Gross Investment Gains (Losses)	The following table presents the sources of fixed maturity proceeds and the related gross investment gains (losses) at December 31, 2018 and 2017: 2018 Fixed Equity Derivative Maturities Securities Instruments (Dollars in thousands) Proceeds from sales or maturities $ 26,633 $ 261 $ 443 Gross gains from sales or maturities 641 261 729 Other-than-temporary-impairment (OTTI) losses (164 ) — — Gross losses from sales or maturities (48 ) — (541 ) 2017 Fixed Equity Derivative Maturities Securities Instruments (Dollars in thousands) Proceeds from sales or maturities $ 23,130 $ 4,043 $ 154 Gross gains from sales or maturities 200 1,957 183 Gross losses from sales or maturities (23 ) — (89 )
Summary of Credit Related Other Than Temporary Impairments ("OTTI") Recognized in Earnings	The following is a rollforward of credit related OTTI recognized in earnings as of December 31, 2018 and 2017: December 31, 2018 December 31, 2017 (Dollars in thousands) Balance at beginning of period $ — $ — Additions for credit related OTTI not previously reported 164 — Additions for increases in OTTI amounts previously recognized — — Balance at end of period $ 164 $ —
Summary of Fair Value and Gross Unrealized Losses Aggregated by Investment Category	The following table shows the fair value and gross unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at December 31, 2018 and December 31, 2017: December 31, 2018 Less than 12 months 12 months or longer Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized Description of securities Value Loss Value Loss Value Loss (Dollars in thousands) U.S. government $ — $ — $ 2,907 $ (148 ) $ 2,907 $ (148 ) States, political subdivisions, other 6,106 (103 ) 9,339 (261 ) 15,445 (364 ) Corporate 49,193 (1,886 ) 14,228 (1,109 ) 63,421 (2,995 ) Residential mortgage-backed securities 9,401 (158 ) 13,065 (530 ) 22,466 (688 ) Commercial mortgage-backed securities 2,003 (45 ) 1,502 (79 ) 3,505 (124 ) Equity securities 379 (38 ) — — 379 (38 ) Total $ 67,082 $ (2,230 ) $ 41,041 $ (2,127 ) $ 108,123 $ (4,357 ) December 31, 2017 Less than 12 months 12 months or longer Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized Description of securities Value Loss Value Loss Value Loss (Dollars in thousands) U.S. government $ 1,161 $ (31 ) $ 1,782 $ (89 ) $ 2,943 $ (120 ) States, political subdivisions, other 8,773 (86 ) 714 (26 ) 9,487 (112 ) Corporate 10,935 (169 ) 6,853 (374 ) 17,788 (543 ) Residential mortgage-backed securities 11,517 (126 ) 2,263 (86 ) 13,780 (212 ) Commercial mortgage-backed securities 2,039 (27 ) 77 (14 ) 2,116 (41 ) Total $ 34,425 $ (439 ) $ 11,689 $ (589 ) $ 46,114 $ (1,028 )
Summary of Net Investment Income	Net investment income for the periods ended December 31, 2018 and 2017 is as follows: December 31, 2018 2017 (Dollars in thousands) Fixed maturity securities $ 7,301 $ 7,350 Equity securities 176 181 Real estate 123 149 Cash equivalents 76 32 Policy loans 711 723 Other 630 685 Subtotal 9,017 9,120 Investment expense 589 597 Net investment income $ 8,428 $ 8,523
Summary of Unrealized Net Capital Gains and Losses	Unrealized net capital gains and losses included in accumulated other comprehensive income at December 31, 2018 and 2017: December 31, 2018 Net Fair Gross Unrealized Unrealized Value Gains Losses Gain (Loss) (Dollars in thousands) Fixed income securities $ 184,475 $ 1,759 $ (4,319 ) $ (2,560 ) Equity securities 6,004 1,528 (38 ) 1,490 Net unrealized capital losses $ (1,070 ) December 31, 2017 Net Fair Gross Unrealized Unrealized Value Gains Losses Gain (Loss) (Dollars in thousands) Fixed income securities $ 188,452 $ 6,048 $ (1,028 ) $ 5,020 Equity securities 6,209 1,766 — 1,766 Net unrealized capital gains $ 6,786

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs, Deferred Sales Inducements and Lifetime Income Benefit Rider Reserves (Tables)	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Summary of Changes In Deferred Acquisition Costs	The balances of and changes in deferred acquisition costs were as follows as of and for the years ended December 31, 2018 and 2017: December 31, 2018 2017 (Dollars in thousands) Balance, beginning of period $ 12,179 $ 11,940 Capitalization of commissions, sales and issue expenses 1,979 2,437 Accrual of interest 550 544 Amortization (2,295 ) (2,659 ) Change in Shadow DAC 1,120 (83 ) Balance, end of period $ 13,533 $ 12,179
Summary of Changes In Deferred Sales Inducement Costs	The balances of and changes in deferred sales inducement costs were as follows as of and for the years ended December 31, 2018 and 2017: December 31, 2018 2017 (Dollars in thousands) Balance, beginning of period $ 867 $ 315 Capitalization of sales inducement costs 381 545 Accrual of interest 34 18 Amortization 66 (11 ) Balance, end of period $ 1,348 $ 867

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2018
Text Block [Abstract]
Accumulated Other Comprehensive Income	The components of accumulated other comprehensive income (loss) are as follows: Unrealized Accumulated Investment Other Gains (Losses) Shadow DAC Comprehensive Income (Loss) (Dollars in thousands) Balance, January 1, 2017 $ 3,997 $ (448 ) $ 3,549 Available-for-sale investment gains (losses) arising during the year: Fixed maturity securities net of tax of $227 440 — 440 Equity securities net of tax of $9 18 — 18 Change in Shadow DAC net of tax benefit of $28 — (55 ) (55 ) Cumulative effect of adoption of new accounting principle (see Note 2) 904 (99 ) 805 Balance, December 31, 2017 5,359 (602 ) 4,757 Available-for-sale investment gains (losses) arising during the year: Fixed maturity securities net of tax benefit of $207 (7,372 ) — (7,372 ) Equity securities net of tax benefit of $63 (235 ) — (235 ) Change in Shadow DAC net of tax of $235 — 885 885 Balance, December 31, 2018 $ (2,248 ) $ 283 $ (1,965 )

Separate Accounts (Tables)

Separate Accounts (Tables)	12 Months Ended
	Dec. 31, 2018
Separate Accounts Disclosure [Abstract]
Schedule of Separate Account Verification	The separate account verification between years is as follows: December 31, 2018 2017 (Dollars in thousands) Balance, beginning of year $ 24,779 $ 21,513 Cost of bonds and stocks acquired 170 299 Net realized and unrealized increase (decrease) (2,272 ) 3,467 Deduction consideration for bonds and stocks disposed of (1,925 ) (562 ) Change in other assets 67 62 Balance, end of period $ 20,819 $ 24,779

Policyholder Liabilities (Table

Policyholder Liabilities (Tables)	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Summary of Future Life and Accident and Health Policy Benefits	Future life and accident and health policy benefits as of December 31, 2018 and 2017 are as follows: December 31, 2018 2017 (Dollars in thousands) Traditional life contracts $ 61,972 $ 62,311 Immediate annuities and pension plan 6,608 6,774 Supplemental contracts with life contingencies 3,118 2,522 Accident and health 345 386 Accident death benefits 132 132 Disability 162 188 $ 72,337 $ 72,313
Schedule of Key Assumptions Used in Calculating the Reserve for Life-Contingent Contract Benefits	The following table highlights the key assumptions generally used in calculating the reserve for life-contingent contract benefits: Product Mortality Interest Rate Estimation Method Immediate fixed annuities 1971, 1983, 2000, and 2012 annuity mortality tables Rates range from 2.3% to 6.5% Present value of expected future benefits based on historical experience Traditional life insurance Actual company experience plus loading Rates range from 2.5% to 5.75% Net level premium reserve method using the Company's withdrawal experience Accident and health Actual company experience plus loading n/a Unearned premium; additional contract reserves for mortality risk
Schedule of Policyholders Account Balances	Policyholder account balances as of December 31, 2018 and 2017 are as follows: December 31, 2018 2017 (Dollars in thousands) Interest sensitive life contracts $ 41,478 $ 41,078 Annuities 74,820 68,745 $ 116,298 $ 109,823
Schedule of Key Contract Provisions Relating to Policyholder Funds	The following table highlights the key contract provisions relating to policyholder funds: Product Interest Rate Withdrawal/surrender charges Interest-sensitive life insurance Rates range from 3% to 7% Either a percentage of account balance or a dollar amount grading off generally over 20 years Fixed annuities Rates range from 0% to 8% Either a declining or level charge generally over 9 years or less Other investment contract Rates range from 2% to 6% No explicit charge assumed
Schedule of Policyholder Funds Activity	Policyholder funds activity for the years ended December 31, 2018 and 2017 is as follows: December 31, 2018 2017 (Dollars in thousands) Balance, beginning of year $ 109,823 $ 99,440 Deposits 14,191 17,994 Interest credited 4,473 4,353 Benefits (2,751 ) (2,734 ) Surrenders and partial withdrawals (5,258 ) (4,835 ) COI charges (2,900 ) (2,973 ) Contract charges (1,316 ) (1,307 ) Net transfers from separate accounts 36 (115 ) Balance, end of period $ 116,298 $ 109,823
Schedule of Reserve for Deposit Type Contracts	Reserve for deposit type contracts as of December 31, 2018 and 2017 are as follows: December 31, 2018 2017 (Dollars in thousands) Payout annuities without life contingencies $ 3,882 $ 3,774 Dividend accumulations and other 6,705 7,076 $ 10,587 $ 10,850

Real Estate (Tables)

Real Estate (Tables)	12 Months Ended
	Dec. 31, 2018
Real Estate [Abstract]
Real Estate Holdings	The following table presents the Company’s real estate holdings at December 31, 2018 and 2017: December 31, 2018 2017 (Dollars in thousands) Land $ 405 $ 405 Building and other 8,485 8,378 8,890 8,783 Accumulated depreciation (6,946 ) (6,828 ) Real estate, net $ 1,944 $ 1,955

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2018
Property Plant And Equipment [Abstract]
Summary of Property and Equipment	Property and equipment is carried at cost less accumulated depreciation. The following table presents the Company’s property and equipment at December 31, 2018 and 2017: December 31, 2018 2017 (Dollars in thousands) EDP equipment $ 3,973 $ 3,955 Furniture 1,596 1,522 EDP equipment & furniture cost 5,569 5,477 Accumulated depreciation (5,383 ) (5,281 ) Property and equipment, net $ 186 $ 196

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Summary of Components of Income Tax Expense	The components of income tax expense for the periods ended December 31, 2018 and 2017 are as follows: For the years ended December 31, 2018 2017 (Dollars in thousands) Current $ 20 $ 34 Deferred — — Provision for income tax $ 20 $ 34
Summary of Federal Income Tax Provisions	The federal income tax provisions differ from the amounts determined by multiplying pre-tax income attributable to the Company by the statutory federal income tax rate of 21% and 34% for December 31, 2018 and 2017, respectively. For the years ended December 31, 2018 2017 (Dollars in thousands) Income tax benefits at statutory rate $ (1,009 ) $ (637 ) Tax effect from change in enacted tax rate — 805 Other 1,029 (134 ) Income tax expense $ 20 $ 34 Effective tax rate 0.4 % 1.8 %
Summary of Significant Portions of Company's Net Deferred Federal Tax Asset (Liability)	The tax effects of temporary differences that give rise to significant portions of the Company’s net deferred federal tax asset (liability) from operations are shown below. For the years ended December 31, 2018 2017 (Dollars in thousands) Deferred federal tax assets: Difference between financial reporting and the tax basis of: Operating loss carryforward $ 3,163 $ 5,859 Other than temporary impairments 974 947 Deferred premiums 846 734 Life policy reserves 821 600 Other 262 380 Deferred reinsurance settlements 555 619 Total deferred tax assets 6,621 9,139 Deferred federal tax liabilities: Difference between financial reporting and the tax basis of: Deferred acquisition costs and sales inducements 2,549 2,147 Net unrealized gains (229 ) 1,421 Reinsurance recoverable 648 766 Amortized discount on bonds 94 138 Other 211 143 Fixed assets (10 ) 53 Total deferred tax liabilities 3,263 4,668 Net 3,358 4,471 Less valuation allowance (2,866 ) (4,013 ) Net deferred tax asset $ 492 $ 458
Summary of Net Operating Loss Carryforwards for Income Tax Purposes	The Company has net operating loss carryforwards for income tax purposes at December 31, 2018 as follows (dollars in thousands): Expiring 2025 3,066 2026 2,188 2027 1,353 2028 2,664 2029 509 2030 2,240 2031 1,119 2032 — N/A 1,921 Total $ 15,060

Retirement and Share-based Co_2

Retirement and Share-based Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Fair Market Value of Stock Options Granted Using Weighted Average Assumptions	The fair market value of the stock options granted during the year ended December 31, 2018, was calculated using the following weighted average assumptions: Expected volatility 39.21 % Expected life (in years) 6.25 Dividend yield 0 % Risk-free interest rate 2.78 % Weighted average grant date fair value of options granted 4.31
Schedule of Changes in Number of Restricted Stock Awards Outstanding	Changes in the number of restricted stock awards outstanding during the years ended December 31, 2018 and 2017 are as follows: Number of Restricted Stock Awards Weighted-Average Grant Date Fair Value per Share (Dollars in thousands, except per share data) Outstanding at January 1, 2017 — $ — Granted — — Canceled — — Exercised — — Outstanding at December 31, 2017 — — Granted 140,000 10.00 Canceled — — Exercised — — Outstanding at December 31, 2018 140,000
Schedule of Changes in Number of Stock Options Outstanding	Changes in the number of stock options outstanding during the years ended December 31, 2018 and 2017 are as follows: Number of Shares Weighted-Average Exercise Price per Share Total Exercise Price (Dollars in thousands, except per share data) Outstanding at January 1, 2017 — $ — $ — Granted — — — Canceled — — — Exercised — — — Outstanding at December 31, 2017 — — — Granted 215,000 10.00 2,150 Canceled — — — Exercised — — — Outstanding at December 31, 2018 215,000 $ 2,150
Summary of Share-based Compensation Expense	The following table summarizes compensation expense, which is all non-cash expense, recognized as a result of share-based compensation: Year Ended December 31, 2018 2017 (Dollars in thousands) Restricted stock awards $ 20 $ — Stock options 14 — $ 34 $ —

Earnings Per Share and Stockh_2

Earnings Per Share and Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Schedule of Pro Forma Net Loss and Weighted Average Common Shares Outstanding Used in Computation of Earnings per Common Share	The following table presents the pro forma net loss and weighted average common shares outstanding used in the computation of earnings per common share and earnings per common share – assuming dilution for the following years: Pro Forma for the years ended December 31, 2018 2017 (Dollar in thousands, except per share data) Numerator: Net loss - numerator for earnings per common share $ (4,826 ) $ (1,908 ) Denominator: Weighted average common shares outstanding 3,530,150 3,530,150 Effect of dilutive securities: Stock options 215,000 215,000 Restricted stock awards 140,000 140,000 Denominator for earnings per common share - assuming dilution 3,885,150 3,885,150 Earnings per common share $ (1.37 ) $ (0.54 ) Earnings per common share - assuming dilution $ (1.37 ) $ (0.54 )

Organization and Basis of Pre_2

Organization and Basis of Presentation - Additional information (Details) $ / shares in Units, $ in Millions	Dec. 11, 2018USD ($)$ / sharesshares	Dec. 31, 2018SubsidiaryState
Organization And Basis Of Presentation [Line Items]
Number of wholly-owned non-insurance subsidiaries | Subsidiary		2
Number of states | State		45
Predecessor
Organization And Basis Of Presentation [Line Items]
Gross Proceeds from issuance of common stock initial public offering | $	$ 35.3
IPO | Predecessor
Organization And Basis Of Presentation [Line Items]
Shares issued | shares	3,530,150
Shares issued, price per share | $ / shares	$ 10

Significant Accounting Polici_3

Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Significant Accounting Policies [Line Items]
Percentage of market/book ratio used as basis screening tool for evaluating potential other-than-temporary impairment (“OTTI”)	80.00%
Time length used as basis screening tool for evaluating potential other-than-temporary impairment ("OTTI") candidates	12 months
Minimum percentage of rapid and significant change in security’s market value in order to analyze underlying factors causing sudden decline in market value	(10.00%)
ASU 2018-02
Significant Accounting Policies [Line Items]
Tax cuts and jobs act, reclassification from AOCI to retained earnings, tax effect		$ 0.8
Participating Life Insurance Policies
Significant Accounting Policies [Line Items]
Percentage of life insurance in-force	93.00%
Non-participating Life Insurance Policies
Significant Accounting Policies [Line Items]
Percentage of life insurance in-force	7.00%
Building
Significant Accounting Policies [Line Items]
Estimated useful life	40 years
Building Improvements
Significant Accounting Policies [Line Items]
Estimated useful life	20 years
Minimum
Significant Accounting Policies [Line Items]
Estimated useful life	3 years
Percentage of policy holders account balances	1.35%
Percentage of interest rate for future policy benefit liabilities	5.00%
Minimum | Other Policyholder Funds
Significant Accounting Policies [Line Items]
Percentage of interest rate for future policy benefit liabilities	2.25%
Maximum
Significant Accounting Policies [Line Items]
Estimated useful life	10 years
Percentage of policy holders account balances	7.00%
Percentage of interest rate for future policy benefit liabilities	9.00%
Maximum | Other Policyholder Funds
Significant Accounting Policies [Line Items]
Percentage of interest rate for future policy benefit liabilities	7.50%

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Carrying Amount and Fair Value of Financial Instruments (Detail) - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Financial instruments recorded as assets:
Equity securities		$ 6,004	$ 6,209
Separate account		20,819	24,779	$ 21,513
Policyholder account balance:
Separate account		20,819	24,779
Carrying Amount
Financial instruments recorded as assets:
Fixed maturity securities		184,475	188,452
Equity securities		6,004	6,209
Policy loans		9,581	9,852
Derivative instruments		202	395
Cash and cash equivalents		33,252	4,085
Separate account		20,819	24,779
Policyholder account balance:
Interest sensitive life contracts		41,478	41,078
Annuities		74,820	68,745
Dividend accumulations and other	[1]	6,705	7,076
Separate account		20,819	24,779
Fair Value
Financial instruments recorded as assets:
Fixed maturity securities		184,475	188,452
Equity securities		6,004	6,209
Policy loans		9,581	9,852
Derivative instruments		202	395
Cash and cash equivalents		33,252	4,085
Separate account		20,819	24,779
Policyholder account balance:
Interest sensitive life contracts		41,478	41,078
Annuities		74,820	68,745
Dividend accumulations and other	[1]	6,705	7,076
Separate account		$ 20,819	$ 24,779
[1]	included within Reserve for deposit type funds in the consolidated balance sheet

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Summary of Securities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Equities		$ 6,004	$ 6,209
Separate accounts		20,819	24,779	$ 21,513
Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		184,475	188,452
Equities		6,004	6,209
Derivative instruments		202	395
Cash equivalents	[1]	33,252	4,085
Separate accounts	[2]	20,819	24,779
Total		244,752	223,920
Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		4,057	4,162
Equities		3,733	4,027
Derivative instruments		202	395
Cash equivalents	[1]	33,252	4,085
Separate accounts	[2]	20,819	24,779
Total		62,063	37,448
Significant Other Observable Inputs (Level 2) | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		180,418	184,290
Total		180,418	184,290
Significant Other Unobservable Inputs (Level 3) | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Equities		2,271	2,182
Total		2,271	2,182
U.S. government | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		4,057	4,162
U.S. government | Quoted Prices in Active Markets for Identical Assets (Level 1) | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		4,057	4,162
States, Political Subdivisions, Other | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		30,989	27,614
States, Political Subdivisions, Other | Significant Other Observable Inputs (Level 2) | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		30,989	27,614
Corporate | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		106,286	109,395
Corporate | Significant Other Observable Inputs (Level 2) | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		106,286	109,395
Residential Mortgage-Backed Securities | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		37,522	43,086
Residential Mortgage-Backed Securities | Significant Other Observable Inputs (Level 2) | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		37,522	43,086
Commercial Mortgage-Backed Securities | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		5,621	4,195
Commercial Mortgage-Backed Securities | Significant Other Observable Inputs (Level 2) | Recurring Fair Value Measurements
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total Fixed maturities		$ 5,621	$ 4,195
[1]	Cash equivalents are invested in money market funds with daily liquidity. The estimated fair value of cash equivalents is based on the estimated fair value of the underlying assets as provided by fund managers in daily net asset values and included in Level 1 assets.
[2]	Separate account assets are invested in money market funds with daily liquidity. The estimated fair value of separate account assets is based on the estimated fair value of the underlying assets as provided by fund managers in daily net asset values and included in Level 1 assets.

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Summary of Quantitative Information About Significant Unobservable Inputs Related to Level 3 Fair Value Measurements (Detail) - Significant Unobservable Inputs (Level 3) $ in Thousands	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Significant Unobservable Inputs, Discount Rate | Fair Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Rreef America REIT II	$ 2,237	$ 2,150
Significant Unobservable Inputs, Discount Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant unobservable inputs	0.0525	0.0550
Significant Unobservable Inputs, Discount Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant unobservable inputs	0.0875	0.0900
Significant Unobservable Inputs, Discount Rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant unobservable inputs	0.0648	0.0661
Significant Unobservable Inputs, Terminal Capitalization Rate | Minimum | Fair Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant unobservable inputs	0.0425	0.0400
Significant Unobservable Inputs, Terminal Capitalization Rate | Maximum | Fair Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant unobservable inputs	0.0814	0.0825
Significant Unobservable Inputs, Terminal Capitalization Rate | Weighted Average | Fair Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Significant unobservable inputs	0.0543	0.0562

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Summary of Rollforward of Level 3 Assets Held at Fair Value on Recurring Basis (Detail) - Significant Unobservable Inputs (Level 3) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance, beginning of period	$ 2,182	$ 3,169
Gains included in net income	0	396
Settlements	0	(1,000)
Unrealized gains (losses) in OCI	89	(383)
Balance, end of period	$ 2,271	$ 2,182

Investments - Summary of Amorti

Investments - Summary of Amortized Cost, Gross Unrealized Gains and (Losses) and Fair Value of the Company's Fixed Maturity and Equities (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Schedule of Available-for-sale [Line Items]
Amortized cost	$ 191,549	$ 187,875
Gross unrealized gains	3,287	7,814
Gross unrealized losses	(4,357)	(1,028)
Fair Value	190,479	194,661
Equity Securities
Schedule of Available-for-sale [Line Items]
Amortized cost	4,514	4,443
Gross unrealized gains	1,528	1,766
Gross unrealized losses	(38)
Fair Value	6,004	6,209
U.S. government
Schedule of Available-for-sale [Line Items]
Amortized cost	4,063	4,075
Gross unrealized gains	142	207
Gross unrealized losses	(148)	(120)
Fair Value	4,057	4,162
States, Political Subdivisions, Other
Schedule of Available-for-sale [Line Items]
Amortized cost	30,881	26,850
Gross unrealized gains	472	876
Gross unrealized losses	(364)	(112)
Fair Value	30,989	27,614
Corporate
Schedule of Available-for-sale [Line Items]
Amortized cost	108,664	106,479
Gross unrealized gains	617	3,459
Gross unrealized losses	(2,995)	(543)
Fair Value	106,286	109,395
Residential Mortgage-Backed Securities
Schedule of Available-for-sale [Line Items]
Amortized cost	37,755	41,818
Gross unrealized gains	455	1,480
Gross unrealized losses	(688)	(212)
Fair Value	37,522	43,086
Commercial Mortgage-Backed Securities
Schedule of Available-for-sale [Line Items]
Amortized cost	5,672	4,210
Gross unrealized gains	73	26
Gross unrealized losses	(124)	(41)
Fair Value	5,621	4,195
Fixed Income Securities
Schedule of Available-for-sale [Line Items]
Amortized cost	187,035	183,432
Gross unrealized gains	1,759	6,048
Gross unrealized losses	(4,319)	(1,028)
Fair Value	$ 184,475	$ 188,452

Investments - Summary of Schedu

Investments - Summary of Scheduled Maturities for Fixed Income Securities (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Investments Debt Securities [Abstract]
Due in one year or less, amortized cost	$ 5,998	$ 2,247
Due after one year through five years, amortized cost	37,917	40,926
Due after five years through ten years, amortized cost	74,274	66,739
Due after ten years, amortized cost	25,419	27,492
Mortgage-backed securities, amortized cost	43,427	46,028
Total, amortized cost	187,035	183,432
Due in one year or less, fair value	6,041	2,288
Due after one year through five years, fair value	38,032	42,809
Due after five years through ten years,fair value	72,209	68,151
Due after ten years, fair value	25,050	27,923
Mortgage-backed securities, fair value	43,143	47,281
Total, fair value	$ 184,475	$ 188,452

Investments - Summary of Fixed

Investments - Summary of Fixed Maturity Proceeds and the Related Gross Investment Gains (Losses) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Schedule of Fixed Maturity Proceeds and Related Gross Investment Gains (Losses) [Line Items]
Other-than-temporary-impairment (OTTI) losses	$ (164)
Fixed Maturities
Schedule of Fixed Maturity Proceeds and Related Gross Investment Gains (Losses) [Line Items]
Proceeds from sales or maturities	26,633	$ 23,130
Gross gains from sales or maturities	641	200
Other-than-temporary-impairment (OTTI) losses	(164)
Gross losses from sales or maturities	(48)	(23)
Equity Securities
Schedule of Fixed Maturity Proceeds and Related Gross Investment Gains (Losses) [Line Items]
Proceeds from sales or maturities	261	4,043
Gross gains from sales or maturities	261	1,957
Derivative
Schedule of Fixed Maturity Proceeds and Related Gross Investment Gains (Losses) [Line Items]
Proceeds from sales or maturities	443	154
Gross gains from sales or maturities	729	183
Gross losses from sales or maturities	$ (541)	$ (89)

Investments - Additional Inform

Investments - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Investments [Line Items]
Other-than-temporary-impairment (OTTI) losses	$ 164
Securities with market value	$ 184,475	$ 188,452
Fixed income maturities rated below investment grade	5.00%
Commercial And Residential Mortgage Backed Securities
Schedule Of Investments [Line Items]
Exposure to total fixed income portfolio	23.00%	25.00%
Consumer Non-cyclical
Schedule Of Investments [Line Items]
Corporate bond sector exposures to total fixed income portfolio	11.00%	12.00%
Banks
Schedule Of Investments [Line Items]
Corporate bond sector exposures to total fixed income portfolio	6.00%	6.00%
Communications
Schedule Of Investments [Line Items]
Corporate bond sector exposures to total fixed income portfolio	6.00%	5.00%
Real Estate
Schedule Of Investments [Line Items]
Corporate bond sector exposures to total fixed income portfolio	5.00%	5.00%
Energy
Schedule Of Investments [Line Items]
Corporate bond sector exposures to total fixed income portfolio	5.00%	6.00%
Deposit With Governmental Agencies
Schedule Of Investments [Line Items]
Securities with market value	$ 4,500	$ 4,700
Corporate Bonds
Schedule Of Investments [Line Items]
Exposure to total fixed income portfolio	57.00%	58.00%

Investments - Summary of Credit

Investments - Summary of Credit Related Other Than Temporary Impairments ("OTTI") Recognized in Earnings (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Investments Debt And Equity Securities [Abstract]
Additions for credit related OTTI not previously reported	$ 164
Additions for increases in OTTI amounts previously recognized	0	$ 0
Balance at end of period	$ 164

Investments - Summary Of Fair V

Investments - Summary Of Fair Value And Gross Unrealized Losses Aggregated By Investment Category (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Schedule of Available-for-sale [Line Items]
Fair Value	$ 67,082	$ 34,425
Gross Unrealized Loss	(2,230)	(439)
Fair Value	41,041	11,689
Gross Unrealized Loss	(2,127)	(589)
Total Fair Value	108,123	46,114
Total Gross Unrealized Loss	(4,357)	(1,028)
Equity Securities
Schedule of Available-for-sale [Line Items]
Fair Value	379
Gross Unrealized Loss	(38)
Fair Value	0
Gross Unrealized Loss	0
Total Fair Value	379
Total Gross Unrealized Loss	(38)
U.S. government
Schedule of Available-for-sale [Line Items]
Fair Value		1,161
Gross Unrealized Loss		(31)
Fair Value	2,907	1,782
Gross Unrealized Loss	(148)	(89)
Total Fair Value	2,907	2,943
Total Gross Unrealized Loss	(148)	(120)
States, Political Subdivisions, Other
Schedule of Available-for-sale [Line Items]
Fair Value	6,106	8,773
Gross Unrealized Loss	(103)	(86)
Fair Value	9,339	714
Gross Unrealized Loss	(261)	(26)
Total Fair Value	15,445	9,487
Total Gross Unrealized Loss	(364)	(112)
Corporate
Schedule of Available-for-sale [Line Items]
Fair Value	49,193	10,935
Gross Unrealized Loss	(1,886)	(169)
Fair Value	14,228	6,853
Gross Unrealized Loss	(1,109)	(374)
Total Fair Value	63,421	17,788
Total Gross Unrealized Loss	(2,995)	(543)
Residential Mortgage-Backed Securities
Schedule of Available-for-sale [Line Items]
Fair Value	9,401	11,517
Gross Unrealized Loss	(158)	(126)
Fair Value	13,065	2,263
Gross Unrealized Loss	(530)	(86)
Total Fair Value	22,466	13,780
Total Gross Unrealized Loss	(688)	(212)
Commercial Mortgage-Backed Securities
Schedule of Available-for-sale [Line Items]
Fair Value	2,003	2,039
Gross Unrealized Loss	(45)	(27)
Fair Value	1,502	77
Gross Unrealized Loss	(79)	(14)
Total Fair Value	3,505	2,116
Total Gross Unrealized Loss	$ (124)	$ (41)

Investments - Summary of Net In

Investments - Summary of Net Investment Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Net Investment Income [Line Items]
Gross, Investment Income	$ 9,017	$ 9,120
Investment expense	589	597
Net investment income	8,428	8,523
Fixed Maturities
Net Investment Income [Line Items]
Gross, Investment Income	7,301	7,350
Equity Securities
Net Investment Income [Line Items]
Gross, Investment Income	176	181
Real Estate Investment
Net Investment Income [Line Items]
Gross, Investment Income	123	149
Cash and Cash Equivalents
Net Investment Income [Line Items]
Gross, Investment Income	76	32
Policy Loans
Net Investment Income [Line Items]
Gross, Investment Income	711	723
Other Long-term Investments
Net Investment Income [Line Items]
Gross, Investment Income	$ 630	$ 685

Investments - Summary of Unreal

Investments - Summary of Unrealized Net Capital Gains and Losses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Debt and Equity Securities, Unrealized Gain Loss [Line Items]
Debt Securities, Unrealized capital gain (losses), Fair value	$ 184,475	$ 188,452
Equity Securities, Unrealized capital gain (losses), Fair value	6,004	6,209
AOCI Attributable to Parent
Debt and Equity Securities, Unrealized Gain Loss [Line Items]
Equity Securities, Unrealized capital gain (losses), Fair value	6,004	6,209
Equity Securities, Gross Unrealized gains	1,528	1,766
Equity Securities, Gross Unrealized losses	(38)
Equity Securities, Unrealized gain (losses), net	1,490	1,766
Debt and Equity Securities, Unrealized gain (losses), net	(1,070)	6,786
Fixed Income Securities | AOCI Attributable to Parent
Debt and Equity Securities, Unrealized Gain Loss [Line Items]
Debt Securities, Unrealized capital gain (losses), Fair value	184,475	188,452
Debt Securities, Gross Unrealized gains	1,759	6,048
Debt Securities, Gross Unrealized losses	(4,319)	(1,028)
Debt Securities, Unrealized gain (losses), net	$ (2,560)	$ 5,020

Derivative Instruments - Additi

Derivative Instruments - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Derivative [Line Items]
Amount of credit risk	$ 0	$ 0
Additional cash requirements	0	0
Net market value	200,000	400,000
Call Option Purchased
Derivative [Line Items]
Call option	12,700,000	8,500,000
Call Option Written
Derivative [Line Items]
Call option	$ 8,800,000	$ 6,000,000

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs, Deferred Sales Inducements and Lifetime Income Benefit Rider Reserves - Summary of Changes In Deferred Acquisition Costs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Deferred acquisition costs [Roll Forward]
Balance, beginning of period	$ 12,179	$ 11,940
Capitalization of commissions, sales and issue expenses	1,979	2,437
Accrual of interest	550	544
Amortization	(2,295)	(2,659)
Change in Shadow DAC	1,120	(83)
Balance, end of period	$ 13,533	$ 12,179

Deferred Policy Acquisition C_4

Deferred Policy Acquisition Costs, Deferred Sales Inducements and Lifetime Income Benefit Rider Reserves - Summary of Changes In Deferred Sales Inducement Costs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Deferred sales inducements [Roll Forward]
Balance, beginning of period	$ 867	$ 315
Deferral of sales inducements	381	545
Accrual of interest	34	18
Amortization	66	(11)
Balance, end of period	$ 1,348	$ 867

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income - Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ 4,757
Available-for-sale investment gains (losses) arising during the year:
Ending balance	(1,965)	$ 4,757
AOCI Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	5,359	3,997
Available-for-sale investment gains (losses) arising during the year:
Cumulative effect of adoption of new accounting principle		904
Ending balance	(2,248)	5,359
AOCI Attributable to Parent | Fixed Maturities
Available-for-sale investment gains (losses) arising during the year:
Securities	(7,372)	440
AOCI Attributable to Parent | Equity Security
Available-for-sale investment gains (losses) arising during the year:
Securities	(235)	18
Shadow Deferred Acquisition Costs
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(602)	(448)
Available-for-sale investment gains (losses) arising during the year:
Change in Shadow DAC	885	(55)
Cumulative effect of adoption of new accounting principle		(99)
Ending balance	283	(602)
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	4,757	3,549
Available-for-sale investment gains (losses) arising during the year:
Change in Shadow DAC	885	(55)
Cumulative effect of adoption of new accounting principle		805
Ending balance	(1,965)	4,757
Accumulated Other Comprehensive Income (Loss) | Fixed Maturities
Available-for-sale investment gains (losses) arising during the year:
Securities	(7,372)	440
Accumulated Other Comprehensive Income (Loss) | Equity Security
Available-for-sale investment gains (losses) arising during the year:
Securities	$ (235)	$ 18

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income - Accumulated Other Comprehensive Income (Parenthetical) (Detail) - AOCI Attributable to Parent - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]
Change in Shadow DAC, tax expense (benefit)	$ 235	$ (28)
Fixed Maturities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Securities, tax expense (benefit)	(207)	227
Equity Security
Accumulated Other Comprehensive Income (Loss) [Line Items]
Securities, tax expense (benefit)	$ (63)	$ 9

Reinsurance and Policy Provis_2

Reinsurance and Policy Provisions - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2018USD ($)Reinsurer	Dec. 31, 2017USD ($)
Ceded Credit Risk [Line Items]
Reinsurance retention limit	$ 250,000
Number of ceded reinsurers | Reinsurer	2
Reinsurance assumed	$ 2,100,000	$ 2,600,000
Reinsurance ceded	2,800,000	2,100,000
Reinsurance recoverables	3,556,000	3,727,000
Prepaid reinsurance premiums	$ 1,418,000	$ 1,358,000
Optimum Re
Ceded Credit Risk [Line Items]
Reinsured risk, percentage	80.00%	80.00%

Separate Accounts - Additional

Separate Accounts - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Separate Accounts Disclosure [Abstract]
Separate account asset	$ 20,819	$ 24,779	$ 21,513

Separate Account - Schedule of

Separate Account - Schedule of Separate Account Verification (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Separate Accounts Disclosure [Abstract]
Balance, beginning of year	$ 24,779	$ 21,513
Cost of bonds and stocks acquired	170	299
Net realized and unrealized increase (decrease)	(2,272)	3,467
Deduction consideration for bonds and stocks disposed of	(1,925)	(562)
Change in other assets	67	62
Balance, end of period	$ 20,819	$ 24,779

Policyholder Liabilities - Summ

Policyholder Liabilities - Summary of Future Life and Accident and Health Policy Benefits (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Liability For Future Policy Benefit By Product Segment [Line Items]
Total future life and accident and health policy benefits	$ 72,337	$ 72,313
Traditional Life Contracts
Liability For Future Policy Benefit By Product Segment [Line Items]
Total future life and accident and health policy benefits	61,972	62,311
Immediate Annuities and Pension Plan
Liability For Future Policy Benefit By Product Segment [Line Items]
Total future life and accident and health policy benefits	6,608	6,774
Supplemental Contracts with Life Contingencies
Liability For Future Policy Benefit By Product Segment [Line Items]
Total future life and accident and health policy benefits	3,118	2,522
Accident and Health
Liability For Future Policy Benefit By Product Segment [Line Items]
Total future life and accident and health policy benefits	345	386
Accident Death Benefits
Liability For Future Policy Benefit By Product Segment [Line Items]
Total future life and accident and health policy benefits	132	132
Disability
Liability For Future Policy Benefit By Product Segment [Line Items]
Total future life and accident and health policy benefits	$ 162	$ 188

Policyholder Liabilities - Sche

Policyholder Liabilities - Schedule of Key Assumptions Used in Calculating the Reserve for Life-Contingent Contract Benefits (Details)	12 Months Ended
	Dec. 31, 2018
Minimum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	5.00%
Maximum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	9.00%
Immediate Fixed Annuities
Liability For Future Policy Benefit By Product Segment [Line Items]
Mortality	1971, 1983, 2000, and 2012 annuity mortality tables
Interest rate description	Rates range from 2.3% to 6.5%
Estimation method	Present value of expected future benefits based on historical experience
Immediate Fixed Annuities | Minimum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	2.30%
Immediate Fixed Annuities | Maximum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	6.50%
Traditional Life Insurance
Liability For Future Policy Benefit By Product Segment [Line Items]
Mortality	Actual company experience plus loading
Interest rate description	Rates range from 2.5% to 5.75%
Estimation method	Net level premium reserve method using the Company's withdrawal experience
Traditional Life Insurance | Minimum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	2.50%
Traditional Life Insurance | Maximum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	5.75%
Accident and Health
Liability For Future Policy Benefit By Product Segment [Line Items]
Mortality	Actual company experience plus loading
Estimation method	Unearned premium; additional contract reserves for mortality risk

Policyholder Liabilities - Su_2

Policyholder Liabilities - Summary of Policyholder Account Balances - (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Liability For Policyholder Account Balance [Line Items]
Policyholder account balances	$ 116,298	$ 109,823	$ 99,440
Interest Sensitive Life Contracts
Liability For Policyholder Account Balance [Line Items]
Policyholder account balances	41,478	41,078
Annuities
Liability For Policyholder Account Balance [Line Items]
Policyholder account balances	$ 74,820	$ 68,745

Policyholder Liabilities - Sc_2

Policyholder Liabilities - Schedule of Key Contract Provisions Relating to Policyholder Funds (Details)	12 Months Ended
	Dec. 31, 2018
Interest-Sensitive Life Insurance
Liability For Future Policy Benefit By Product Segment [Line Items]
Withdrawal/surrender charges	Either a percentage of account balance or a dollar amount grading off generally over 20 years
Interest-Sensitive Life Insurance | Minimum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	3.00%
Withdrawal/surrender charges term	20 years
Interest-Sensitive Life Insurance | Maximum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	7.00%
Fixed Annuities
Liability For Future Policy Benefit By Product Segment [Line Items]
Withdrawal/surrender charges	Either a declining or level charge generally over 9 years or less
Fixed Annuities | Minimum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	0.00%
Fixed Annuities | Maximum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	8.00%
Withdrawal/surrender charges term	9 years
Other Investment Contract
Liability For Future Policy Benefit By Product Segment [Line Items]
Withdrawal/surrender charges	No explicit charge assumed
Other Investment Contract | Minimum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	2.00%
Other Investment Contract | Maximum
Liability For Future Policy Benefit By Product Segment [Line Items]
Interest rate	6.00%

Policyholder Liabilities - Sc_3

Policyholder Liabilities - Schedule of Policyholder Funds Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Insurance [Abstract]
Balance, beginning of year	$ 109,823	$ 99,440
Deposits	14,191	17,994
Interest credited	4,473	4,353
Benefits	(2,751)	(2,734)
Surrenders and partial withdrawals	(5,258)	(4,835)
COI charges	(2,900)	(2,973)
Contract charges	(1,316)	(1,307)
Net transfers from separate accounts	36	(115)
Balance, end of period	$ 116,298	$ 109,823

Policyholder Liabilities - Sc_4

Policyholder Liabilities - Schedule of Reserve for Deposit Type Contracts (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Liability For Future Policy Benefit By Product Segment [Line Items]
Reserve for deposit type contracts	$ 10,587	$ 10,850
Payout annuties without life contingencies
Liability For Future Policy Benefit By Product Segment [Line Items]
Reserve for deposit type contracts	3,882	3,774
Dividend accumulations and other
Liability For Future Policy Benefit By Product Segment [Line Items]
Reserve for deposit type contracts	$ 6,705	$ 7,076

Real Estate - Summary of Compan

Real Estate - Summary of Company's Real Estate Holdings (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Real Estate [Abstract]
Land	$ 405	$ 405
Building and other	8,485	8,378
Real Estate, gross	8,890	8,783
Accumulated depreciation	(6,946)	(6,828)
Real estate, net	$ 1,944	$ 1,955

Property and Equipment - Summar

Property and Equipment - Summary of Property and Equipment (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 5,569	$ 5,477
Accumulated depreciation	(5,383)	(5,281)
Property and equipment, net	186	196
EDP Equipment
Property Plant And Equipment [Line Items]
Property and equipment, gross	3,973	3,955
Furniture
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 1,596	$ 1,522

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Contingency [Line Items]
Estimated annual limit of loss carryforward	$ 1,000,000
Estimated total limit of loss carryforward	15,000,000
Net operating loss carryforwards	15,060,000
Net deferred tax asset	492,000	$ 458,000
Loss carryforwards, subject to expiration	$ 13,100,000
Operating loss carry forwards expiration year start	2025
Operating loss carry forwards expiration year end	2032
Liability for unrecognized tax benefits	$ 0	$ 0
Accrued for interest or penalties of unrecognized tax benefits	$ 0
Statutory federal income tax rate	21.00%	34.00%
Percentage limit of deduction on taxable income with no carrybacks and indefinite carryforwards	80.00%
Minimum
Income Tax Contingency [Line Items]
Percentage Of Life Reserve for tax purpose	92.81%

Income Taxes - Summary of Compo

Income Taxes - Summary of Components of Income Tax Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Current	$ 20	$ 34
Deferred	0	0
Provision for income tax	$ 20	$ 34

Income Taxes - Summary of Feder

Income Taxes - Summary of Federal Income Tax Provisions (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income tax benefits at statutory rate	$ (1,009)	$ (637)
Tax effect from change in enacted tax rate		805
Other	1,029	(134)
Provision for income tax	$ 20	$ 34
Effective tax rate	0.40%	1.80%

Income Taxes - Summary of Signi

Income Taxes - Summary of Significant Portions of Company's Net Deferred Federal Tax Asset (Liability) (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Operating loss carryforward	$ 3,163	$ 5,859
Other than temporary impairments	974	947
Deferred premiums	846	734
Life policy reserves	821	600
Other	262	380
Deferred reinsurance settlements	555	619
Total deferred tax assets	6,621	9,139
Deferred acquisition costs and sales inducements	2,549	2,147
Net unrealized gains	(229)	1,421
Reinsurance recoverable	648	766
Amortized discount on bonds	94	138
Other	211	143
Fixed assets	(10)	53
Total deferred tax liabilities	3,263	4,668
Net	3,358	4,471
Less valuation allowance	(2,866)	(4,013)
Net deferred tax asset	$ 492	$ 458

Income Taxes - Summary of Net O

Income Taxes - Summary of Net Operating Loss Carryforwards for Income Tax Purposes (Detail) $ in Thousands	Dec. 31, 2018USD ($)
Income Tax Contingency [Line Items]
Net operating loss carryforwards	$ 15,060
2025
Income Tax Contingency [Line Items]
Net operating loss carryforwards	3,066
2026
Income Tax Contingency [Line Items]
Net operating loss carryforwards	2,188
2027
Income Tax Contingency [Line Items]
Net operating loss carryforwards	1,353
2028
Income Tax Contingency [Line Items]
Net operating loss carryforwards	2,664
2029
Income Tax Contingency [Line Items]
Net operating loss carryforwards	509
2030
Income Tax Contingency [Line Items]
Net operating loss carryforwards	2,240
2031
Income Tax Contingency [Line Items]
Net operating loss carryforwards	1,119
N/A
Income Tax Contingency [Line Items]
Net operating loss carryforwards	$ 1,921

Employer's Disclosures About _2

Employer's Disclosures About Postretirement Benefits - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Tax Status [Extensible List]	us-gaap:QualifiedPlanMember	us-gaap:QualifiedPlanMember
Maximum contribution by employees, percentage of pretax cash contribution	10.00%
Company's contribution cost	$ 95,000	$ 90,000
Maximum
Defined Contribution Plan Disclosure [Line Items]
Company's matching employee contribution of cash compensation, percentage	3.00%
Additional company's matching employee contribution of cash compensation, percentage	3.00%

Debt and Federal Home Loan Ba_2

Debt and Federal Home Loan Bank Advances - Additional Information (Detail) - USD ($)	Dec. 11, 2018	Dec. 31, 2018	Jun. 29, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Advances with FHLB		$ 0		$ 0
Other credit obligations		0
Commitments in form of loan guarantees		$ 0
Promissory Notes | Insurance Capital Group
Debt Instrument [Line Items]
Debt instrument, principal amount			$ 2,000,000
Debt instrument, interest rate			3.75%
Debt instrument outstanding	$ 1,050,000
Conversion of debt instrument into shares	105,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Sep. 06, 2017	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Related Party Transactions By Related Party [Line Items]
Amount settlement descriptions		60 days
Americana.
Schedule Of Related Party Transactions By Related Party [Line Items]
Common stock dividends to Federal Life		$ 500,000	$ 1,400,000
Dividends due to Federal Life		100,000	41,000
Federal Life Mutual Holding Company.
Schedule Of Related Party Transactions By Related Party [Line Items]
Paid-in surplus from parent		12,500,000
Interest paid to federal life		$ 20,000	$ 20,000
FEDHO Holding Company.
Schedule Of Related Party Transactions By Related Party [Line Items]
Dividend distribution	$ 3,050,000

Retirement and Share-based Co_3

Retirement and Share-based Compensation Plans - Additional Information (Detail) $ / shares in Units, $ in Millions	Dec. 11, 2018shares	Dec. 31, 2018USD ($)Anniversary$ / sharesshares	Oct. 23, 2018shares
Restricted Stock Awards
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Number of shares, granted		140,000
Grant date fair market value | $		$ 1.4
Stock Option Award
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Number of shares, granted		215,000
Stock options exercise price at grant date | $ / shares		$ 10
Dividend yield percentage		0.00%
Estimated grant date fair value | $		$ 0.9
2018 Equity Incentive Plan
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Restricted stock awards and options granted, vesting period		4 years
Restricted stock awards and options granted, vesting percentage		25.00%
Restricted stock awards and options granted, number of anniversaries | Anniversary		3
Stock options, contractual term		10 years
Stock options exercise price at grant date | $ / shares		$ 10
Restricted stock awards and options granted, vesting description		All restricted stock awards and options granted under the Plan have a service vesting period of 4 years, vesting 25% on December 10, 2019, and the subsequent three anniversaries of such date.
2018 Equity Incentive Plan | Restricted Stock Awards
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Number of shares, granted	140,000
2018 Equity Incentive Plan | Stock Option Award
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Number of shares, granted	215,000
Common Stock | 2018 Equity Incentive Plan
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Number of shares, future grant		125,000
Common Stock | 2018 Equity Incentive Plan | Maximum
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Number of shares authorized			480,000

Retirement and Share-based Co_4

Retirement and Share-based Compensation Plans - Summary of Fair Market Value of Stock Options Granted Using Weighted Average Assumptions (Detail) - Stock Option Award	12 Months Ended
	Dec. 31, 2018$ / shares
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Expected volatility	39.21%
Expected life (in years)	6 years 3 months
Dividend yield	0.00%
Risk-free interest rate	2.78%
Weighted average grant date fair value of options granted	$ 4.31

Retirement and Share-based Co_5

Retirement and Share-based Compensation Plans - Schedule of Changes in Number of Restricted Stock Awards Outstanding (Detail) - Restricted Stock Awards	12 Months Ended
	Dec. 31, 2018$ / sharesshares
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Number of Restricted Stock Awards, Granted	140,000
Number of Restricted Stock Awards, Outstanding ending balance	140,000
Weighted Average Grant Date Fair Value Per Share, Granted | $ / shares	$ 10

Retirement and Share-based Co_6

Retirement and Share-based Compensation Plans - Schedule of Changes in Number of Stock Options Outstanding (Detail) - Stock Option Award $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)$ / sharesshares
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Number of Shares, Granted | shares	215,000
Number of Shares, Outstanding ending balance | shares	215,000
Weighted Average Exercise Price, Granted | $ / shares	$ 10
Total Exercise Price, Granted | $	$ 2,150
Total Exercise Price, Outstanding ending balance | $	$ 2,150

Retirement and Share-based Co_7

Retirement and Share-based Compensation Plans - Summary of Share-based Compensation Expense (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 34
Restricted Stock Awards
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Allocated Share-based Compensation Expense	20
Stock options
Share Based Compensation Arrangement by Share Based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 14

Statutory Financial Informati_2

Statutory Financial Information and Dividend Restrictions - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Minimum | Federal Life Holding Company
Statutory Accounting Practices [Line Items]
Insurance regulations required to maintain surplus	$ 2
Illinois
Statutory Accounting Practices [Line Items]
Statutory gain (loss)	(2.6)	$ 0.2
Statutory capital and surplus, balance	24.9	$ 14.9
Amount of restricted net assets	$ (22.4)
Percentage of capital and surplus	90.00%
Illinois | Federal Life Mutual Holding Company.
Statutory Accounting Practices [Line Items]
Statutory accounting practices statutory capital and surplus without approval reduced balance	$ 2
Statutory accounting practices statutory capital and surplus without approval decrease balance	22.9
Illinois | Federal Life Mutual Holding Company. | Guaranty Fund Note
Statutory Accounting Practices [Line Items]
Permitted practice amount	2
Illinois | Minimum
Statutory Accounting Practices [Line Items]
Insurance regulations required to maintain surplus	$ 1.5

Earnings Per Share and Stockh_3

Earnings Per Share and Stockholders' Equity - Schedule of Pro Forma Net Loss and Weighted Average Common Shares Outstanding Used in Computation of Earnings per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Numerator:
Net loss - numerator for earnings per common share	$ (4,826)	$ (1,908)
Denominator:
Weighted average common shares outstanding	3,530,150	3,530,150
Denominator for earnings per common share - assuming dilution	3,885,150	3,885,150
Earnings per common share	$ (1.37)	$ (0.54)
Earnings per common share - assuming dilution	$ (1.37)	$ (0.54)
Stock options
Denominator:
Effect of dilutive securities	215,000	215,000
Restricted stock awards
Denominator:
Effect of dilutive securities	140,000	140,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - $ / shares	Jan. 16, 2019	Apr. 01, 2019	Dec. 31, 2018	Dec. 16, 2018	Dec. 31, 2017
Subsequent Event [Line Items]
Common stock, shares outstanding			3,530,150	3,530,150	0
Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock, shares outstanding		3,530,250
IPO | Subsequent Event [Member]
Subsequent Event [Line Items]
Initial public offering/conversion, shares	100
Common stock, per share	$ 10